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The constant development of technologies capable to define features at 
the level of single cells enabled to investigate cellular heterogeneity that 
was previously inaccessible due to population averaging. In this work, I 
took advantage of cutting-edge single cell technologies to unravel 
functional diversification within the human CD8+ T cell compartment, with 
the final aim to identify T cell subsets that can exert superior effector 
responses against viruses and cancer. In mice, the capability to exert 
effector responses correlates with TCR sensitivity for self-Ags, as 
assessed by indirect measurement of surface expression of CD5. 
Equivalent functional heterogeneity has not been previously described in 
humans. We investigated the CD8+ naïve T (TN) cell pool, and discovered 
the presence of two discrete subsets with distinct effector differentiation 
potential, as defined by the differential expression of the chemokine 
receptor CXCR3. Among these, CXCR3+ (TNR3+) cells showed increased 
cytokine production and effector differentiation potential, both in vitro and 
in vivo. These features correlated with the expression of T cell receptors 
suggesting enhanced interactions with p:MHC-I complexes. Thus, 
functional heterogeneity exists in CD8+ TN cells, thereby showing that the 
effector differentiation potential is predetermined at the level of pre-
immune repertoire. 
Stem-like characteristics of T cells have been a long-standing interest of 
the lab. T cell memory relies on the generation of antigen-specific 
precursors with stem-like properties. However, precise definition of these 
progenitors and how they shape memory and effector differentiation is still 
unclear. We characterized subsets of clonally, phenotypically, functionally, 
epigenetically and transcriptionally distinct stem-like CCR7+ CD8+ memory 
 2 
T cells, identified by the presence or absence of inhibitory receptors PD-1 
and TIGIT. We found that PD-1-TIGIT- progenitors were committed to a 
functional lineage, while PD-1+TIGIT+ progenitors were committed to a 
dysfunctional, exhausted-like lineage. Collectively, these data demonstrate 
the existence of parallel differentiation programs within the early-
differentiated CD8+ memory T cell compartment, providing fundamental 
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1  Introduction 
1.1  Adaptive immunity: the T cell compartment 
T lymphocytes belong to the adaptive immune system and play a role in 
cell-mediated immunity. Their progenitors arise from multipotent 
haematopoietic stem cells (HSC) in the bone marrow (BM) which migrate 
to the thymus to undergo a process of maturation that includes the 
rearrangement of the T cell receptor (TCR) genes. TCRs ensure antigen 
recognition through interactions with peptides processed and presented by 
major histocompatibility complex (MHC) class II molecules, that are 
present on antigen-presenting cells (APCs), or class I molecules, that are 
present on nearly all cells in the body1. The TCR is a variable αβ or γδ 
heterodimer coupled with the non-variable signal transduction CD3 
complex, which in turn contains γε, δε, and ζζ subunits2. T cells are 
classified in αβ T lymphocytes, and γδ lymphocytes depending on whether 
α and β or γ and δ chains compose the heterodimeric TCR3.  
Mature T cells differentiate in the thymus, where different stages of 
differentiation can be identified on the basis of combinatorial expression of 
CD4 and CD8 coreceptor molecules. During the double negative phase 
(DN), CD4- CD8- thymocytes rearrange variable (V), diversity (D) and 
joining (J) segments of the locus encoding TCR β. During the double 
positive phase (DP), CD4+ CD8+ thymocytes undergo rearrangement of V 
and J segments of the locus encoding TCRα. The addition and subtraction 
of nucleotides at the gene segment junctions4,5 also occurs in order to 
increase genetic diversity. Rearrangement of these gene segments 
generates a repertoire of ~2.5 × 108 different TCRs6. However, the pool of 
possible peptides generated by combination of 20 amino acids and 
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presented by MHC molecules is ideally >1015, and led to hypothesize that 
high levels of TCR degeneracy are required to cover the full spectrum of 
possible peptides. In support of this hypothesis, it has been shown that a 
single TCR is able to recognize >106 different peptides7.  
At the DP stage, TCR rearrangement is followed by positive and negative 
selection of thymocytes8. Positive selection is the process by which 
thymocytes become restricted by the host MHC: only those thymocytes 
able to bind self-peptide:MHC (p:MHC) complexes with weak but sufficient 
affinity will survive and will be positively selected8. Conversely, T cells 
bearing TCRs that react too strongly with self-p:MHC complexes will 
undergo apoptosis, i.e., they will be eliminated by negative selection8. This 
mechanism ensures that only thymocytes capable to recognize self 
peptides with sufficient, although not too strong affinity can be released in 
the periphery. It is currently estimated that around 75% of thymocytes are 
eliminated by negative selection9. Mature T cells are thus released in the 
periphery as naïve T cells (TN), which retain low levels of reactivity to self 
p:MHCs. This is insufficient to induce an autoimmune response, but is 
required to promote their survival and homeostasis by slow 
proliferation10,11.  
Although pivotal in order to effectively remove potentially autoreactive T 
cells from the T cell repertoire, thymic negative selection is only 60-70% 
efficient12, thus additional peripheral tolerance mechanisms are necessary. 
Not all self-antigens are expressed at sufficient levels in the thymus to 
ensure a complete elimination of all autoreactive T cells. Moreover, 
although negative selection is highly efficient in eliminating T cells of high 
avidity for self-peptides, low avidity T cells are often spared. A first layer of 
maintenance of immunological tolerance in the periphery is due to the 
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abovementioned affinity threshold of TCR-p:MHC interaction. In fact, 
thymic deletion requires a lower affinity compared to the one required for 
activation in the periphery13, thus mature T cells that escape negative 
selection will show low reactivity to self-ags, and thus be refractory to 
peripheral activation14. The quiescent state of TN cells, alongside ag 
ignorance, constitute the intrinsic mechanisms by which peripheral 
tolerance is exerted prior to TCR engagement. After ag-specific TCR 
activation, extrinsic mechanisms play an effective role in the maintenance 
of peripheral tolerance. Self-ags are presented in SLOs to TN cells by DCs 
which, in absence of pathogens, are in a quiescent state which is 
characterized by low levels of costimulatory molecules, such as B7.1 and 
B7.2, which bind the costimulatory receptor CD28. T cell activation in 
absence of a second signal (costimulation) results in suboptimal 
proliferation and effector function capabilities, resulting in the persistence 
of “anergic” T cells, characterized by a long-term state of 
hyporesponsiveness and repression of TCR signaling, or elimination by 
clonal deletion15. 
TN cells leave the thymus and migrate through the lymph and blood to 
secondary lymphoid organs (SLO) such as the spleen and lymph nodes, 
where they continuously scan APCs for the presence of cognate 
exogeneous antigens16. If a cognate antigen is recognized via TCR-
p:MHC interaction, TN cells initiate a process of clonal expansion, 
characterized by high proliferative rate and the acquisition of effector 
functions that ensure the elimination of pathogen-infected cells17. After 
antigen is cleared, the vast majority of TN-derived effector T cells die, and 
only a small fraction of approximately 5% of these cell will survive, giving 
rise to a population of clonally expanded  long-lived  memory T cells 
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(TMEM)18, that will provide a more rapid recall response compared to TN 
and will confer protection against a secondary antigen exposure.  
 
1.2  Heterogeneity and differentiation of the T cell 
compartment 
The T cell memory compartment is characterized by high heterogeneity. 
Indeed, it is composed by a plethora of subsets that are different in terms 
of phenotype, functional activity and capability to respond to homeostatic 
or antigenic simulation19. Sallusto and Lanzavecchia proposed that human 
memory CD4+ and CD8+ T cells can be subdivided into two main subsets, 
central memory (TCM) and effector memory (TEM), on the basis of their 
capability to migrate in the body. In fact, TCM express CC chemokine 
receptor-7 (CCR7) and L-selectin (CD62L), regulating homing towards 
SLOs, and for this reason are preferentially found at these sites compared 
to TEM, which instead are more abundant in peripheral tissues. Compared 
to TCM, TEM cells display increased expression of transcription factors 
(TFs) and molecules driving terminal differentiation such as Zinc finger E-
box-binding homeobox 2 (ZEB2), Inhibitor of DNA-binding 2 (ID2) and PR 
domain zinc finger protein 1 (PRDM1, also known as Blimp-1), among 
others, display more rapid effector responses, characterized by IFN-γ and 
TNF but not IL-2 production, and proliferate less extensively19. On the 
other hand, TCM express elevated levels of molecules responsible for long-
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term persistence and survival, have increased proliferative potential and 
are slower in mediating effector functions compared to TEM20–22.  
The memory T cell compartment possesses an intrinsic capability of self-
maintenance in the long term, according to which TCM were first proposed 
to behave in a stem cell-like fashion, i.e., to self-renew while generating 
more differentiated progeny23. Recent work in mice, rhesus macaque and 
humans discovered a new memory T cell population displaying enhanced 
stem cell-like features compared to TCM and termed T stem cell memory 
(TSCM)24–26. This rare subset, representing 3% of all circulating CD4+ and 
CD8+ T cells in humans, shows a naïve-like phenotype but at the same 
time possess clearly distinct memory traits such as expression of memory 
markers CD95 and CD122, lower T Cell Receptor Excision Circles content 
(TRECs) compared to TN (indicating higher number of rounds of cell 
Figure 1: T cell differentiation pattern. Polychromatic flow cytometry 
analysis allows the identification of each T subset in the T cell compartment. 
Each T subset is characterized by the expression of specific markers. In red, 
the markers that change during differentiation from the previous subset. 
Going from less differentiated T cells to more differentiated ones, functional 
abilities also change. Adapted from Mahnke et al., Eur J Immunol 2013. 
 11 
division) and cytokine producing capacity similar to that of conventional 
memory T cells. Indeed, upon superantigen stimulation, TSCM display rapid 
production of IL-2, TNF-a and IFN-γ, however with lower polifunctionality 
compared to TCM and TEM. TSCM also retain stem cell-like qualities, 
including a higher capacity to self-renew in vitro and to generate more 
differentiated progeny compared to TCM. Indeed, after anti-CD3/CD2/CD28 
stimulation, which induces T cell differentiation, TSCM demonstrate an 
increased capacity to maintain their original phenotype when compared 
with TCM25, while capable to give rise to all other memory subsets 
(multipotency)25,27. Multiple rounds of antigen stimulation favour the 
generation of terminal effector T (TTE) cells27,28, with low proliferation rate, 
probably as a consequence of extensive telomere shortening29, among 
other causes, and poor persistence following transfer in vivo, although still 
capable to exert potent effector functions upon cognate antigen 
recognition27. Collectively, these observations suggest that T cell 
differentiation progresses in a linear fashion, according to the relationship 
TNà TSCMàTCMàTEMàTTE 25,27, and where specific functional capacities 
are progressively lost, such as proliferative capacity, stemness, and 
lymphoid homing, or acquired, such as  cytotoxic capability, peripheral 
tissue homing and terminal differentiation/senescence25,26,30 (Fig 1). 
 
1.3  Homeostasis of human T cells 
T cell numbers in the body are tightly regulated by homeostatic 
proliferation, a turnover occurring at slow rate in the absence of 
exogenous antigen31. In this regard, tonic TCR signalling driven by 
interactions with self-derived Ags together with additional signals provided 
by common γ chain (γc) cytokines, including IL-2, IL-7 and IL-15, play a 
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role10. While cytokine signalling is sufficient for the homeostasis of 
memory T cells, both signals are required for the homeostasis of TN cells. 
In young individuals, where the thymus is fully functional, the vast majority 
of peripheral T cells is composed by newly generated TN cells. With aging, 
due to thymus atrophy, there is little de novo generation of new T cells, 
thus continuous exposure to environmental Ags causes the accumulation 
of memory T cells10.  
 
1.3.1  Naïve T cell homeostasis 
The requirement for TCR signalling for TN cell survival and homeostasis 
was firstly described more than 20 years ago. Work from Takeda et al 
demonstrated that newly generated CD4+ TN cells originated from the 
thymuses grafted in control immunodeficient RAG 2-/- and MHC-II-/-  
RAG 2-/- mice proliferated at the same extent. Nevertheless, CD4+ T cells 
in the MHC-II-/- RAG 2-/- recipient failed to persist, displaying a massive 
reduction in absolute number over 6 months, thus demonstrating that 
TCR-p:MHC-II interactions are fundamental tor the maintenance of the T 
cell pool in the long term32. Subsequent work from Tanchot et al identified 
a similar, although faster decay of murine CD8+ TCR-transgenic TN cells 
over time after transfer in MHC-I-deficient hosts, confirming the necessity 
of TCR-p:MHC interactions for the survival of the TN cell pool33. 
Alongside TCR signalling, IL-7 plays an essential role for the survival of TN 
cells. Several experimental approaches were utilized to demonstrate the 
fundamental requirement of IL-7 in this regard. Works from Tan et al 
discovered that both CD4+ and CD8+ TN cells displayed a lower 
proliferation rate, and were able to survive only two weeks, according to 
carboxyfluorescein succinimydil ester (CFSE) dye dilution, after transfer 
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into syngeneic T-depleted IL-7 deficient mice when compared to those 
transferred in wild-type (WT) animals34. Similarly, injections of anti-IL-7 
monoclonal antibodies in thymectomized WT C57BL/6 mice resulted in 
curtailed cell numbers of TN cells35. On the other hand, transgenic 
overexpression of IL-7 in mice in vivo revealed an increased number of 
naïve T cell counts36. Collectively, these observations support the notion 
that IL-7 is necessary for TN cells survival and that the availability of IL-7 
strictly correlates with the extent of the TN pool. 
From a mechanistic point of view, IL-7 binding to CD127 (IL-7Ra) and γc 
induces signals mediated by JAK1 and JAK3 pathways, which in turn lead 
to the activation of STAT5a and STAT5b, which migrate into the nucleus 
to regulate transcription37. IL-7 is able to promote cell survival by 
preventing the mitochondrial pathway of apoptosis. BCL-2 and MCL-1 are 
the main antiapoptotic molecules expressed by TN cells, and they regulate 
BAD and BAX, which are apoptotic inducers, capable of triggering the 
cytochrome-c release from mitochondria and the caspase cascade38. IL-7 
induces increased expression of BCL-2, as demonstrated by the work of 
Qin et al using a cutaneous T-cell lymphoma (CTCL) system39.  
 
1.3.1.1  Homeostatic proliferation of Naïve T cells 
As mentioned above, homeostatic proliferation of TN cells is very slow in 
physiological conditions (it has been estimated that TN cells divide every 1 
to 6  years23), but becomes fast in the context of severe T cell depletion. 
Such proliferation can be induced by several signals, and thus different 




1.3.1.2  Homeostatic proliferation driven by self-p:MHC and IL-7 
When the total size of the T cell pool is acutely reduced following 
irradiation, viral infections or cytotoxic drugs, consumption of IL-7 is 
drastically decreased, thus leading to increased availability of circulating 
IL-740,41. In this context, a combination of IL-7 and self-p:MHC elicits 
increased rates of homeostatic proliferation, according to which TN cells 
divide every 24-36 hours42. During this Lymphopenia Induced Proliferation 
(LIP), the proliferating cells acquire phenotypical and functional 
characteristics of memory T cells43. Several studies addressed the 
importance of p:MHC interactions: according to work from Goldrath and 
Bevan, polyclonal T cells displayed an impaired capability to undergo LIP 
upon transfer in TAP-deficient mice expressing low levels of MHC class I, 
as assessed by CFSE dilution assay44. Furthermore, TCR transgenic OT-I 
T cells underwent LIP even in the absence of cognate Ag, thus 
highlighting the importance of self-p:MHC interactions for LIP44.  
TCR affinity for self-p:MHC-I ligands also play a role in triggering LIP. 
According to work from Kieper et al, OT-I T cells, which are characterized 
by high TCR affinity, were capable to undergo LIP at a fast rate upon 
transfer in irradiated lymphopenic hosts45. On the contrary, T cell lines with 
lower (2C T cells) or very low TCR affinity (HY cell line) displayed slower 
rate or almost absent LIP, respectively, when compared to OT-I T cells45. 
Alongside with TCR affinity, several data demonstrated the importance of 
molecules capable to modulate TCR signalling in the context of LIP. In this 
regard, T cells lacking the TCR negative regulators CD223 (LAG-3, which 
binds to high affinity MHC-II), BTLA-4 (which binds to HVEM, a TNF 
receptor) and SIT (a tyrosine phosphatase 2-binding protein) displayed a 
faster rate of LIP when compare to WT T cells46–48. Costimulatory 
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molecules are necessary for response to foreign Ags, but they do not play 
a role in the context of LIP. The only costimulatory molecule that is 
important for TN cells in response to self-p:MHC ligands is CD24, since 
CD24-deficient T cells displayed reduced capacity of homeostatic 
proliferation in lymphopenic hosts49.  
To summarize, in acute lymphopenic hosts, TN cells undergo LIP, which 
relies on self-p:MHC interactions of relatively high affinity, and on 
increased concentrations and availability of IL-7, in the absence of 
costimulatory signals. 
 
1.3.1.3  Homeostatic proliferation driven by other cytokines 
Besides IL-7, TN cells can undergo homeostatic proliferation also in the 
presence of high concentrations of other γc cytokines such as IL-2 and IL-
15, even in the absence of lymphopenia. IL-2 and IL-15 share two of their 
three receptor chains, the IL-2/15 Rβ (CD122) and the common γc 
(CD132)50. IL-2 and IL-15 also share downstream signalling, which 
involves the induction of mitogen-activated protein kinase (MAPK) and 
BCL-2, and the phosphorylation of spleen tyrosine kinase (Syk) and of 
lymphocyte-activated protein tyrosine kinase (Lck)50. The most prevalent 
form of IL-15 in vivo is a membrane-bound form, where IL-15 binds with 
high affinity to IL-15Rα, thereby signalling to target cells by trans-
presentation51. In the non-complexed form, however, IL-15 can still bind 
the 15Rβγ signalling complex, although at lower affinity. Receptor binding 
triggers the activation of PI3K and MAPK signalling pathways52.  
A role for IL-2 and IL-15 in sustaining T cells homeostatic proliferation 
were first discovered more than 10 years ago. Work from Cho et al, 
demonstrated that small amounts (106) of WT TN cells injected in non-
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irradiated CD122-/- mice proliferated massively, around 100-fold more 
when compared to acutely lymphopenic (irradiated) B6 hosts53. This fast 
tempo of proliferation was significantly higher in CD8+ than in CD4+ T 
cells, and required self-p:MHC interactions53. Interestingly, in this scenario 
of Cytokine Induced Proliferation (CIP), cells proliferated at a rate which is 
comparable to that occurring with foreign Ag stimulation, and the resulting 
progeny rapidly acquire a TEM or TCM phenotypes in the presence of high 
concentrations of IL-2 and IL-15, respectively53,54. Notably, Il-2ra-/- and Il-
2rb-/--deficient mice display massive lymphadenopathy, thus indicating that 
this kind of homeostatic proliferation does not strictly require lymphopenic 
conditions, and that the quality of the proliferative response is a reflection 
of the stimulatory capacity of the cytokines involved10. Regarding this, IL-2 
and IL-15 represent stronger proliferative and differentiative signals 
compared to IL-7, thus their production needs to be strictly regulated in 
order to avoid massive activation of bystander TN cells in the context of 
strong immune responses10.  
Under physiological conditions, IL-2 has a minor role in controlling T cell 
homeostasis, except for regulatory T cells (Treg), while IL-15 promotes TN 
homeostasis, as assessed by work from Berard et al which demonstrated 
that in IL-15-deficient mice total count if TN cells was highly impaired55.  
 
1.3.1.4  Homeostatic proliferation driven by commensal Ags 
As previously stated, homeostatic proliferation relies mainly on self-p:MHC 
interactions10. Nevertheless, also foreign Ags play a role in this regard56. 
In particular, when WT mice are rendered acutely lymphopenic by 
irradiation, LIP is triggered by self rather than foreign Ags10. On the 
contrary, foreign Ags drive a chronic Lymphopenia-Induced Proliferation 
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(cLIP) in chronically lymphopenic hosts, such as RAG-deficient, SCID, 
nude mice or TCR deficient mice10. This was supported by the evidence 
that that cLIP, but not LIP is abolished in mice raised in germ-free 
conditions, thus suggesting that the source of Ags is provided by the 
commensal microflora of the chronically lymphopenic hosts56. Additional 
evidence that cLIP is triggered by foreign Ags is provided by the fact that 
proliferating cells required CD28 costimulation and rapidly upregulated 
activation markers, such as CD25, and acquired effector functions, 
according to TNF-a and IFN-γ production56.  
 
1.3.2  Homeostasis of memory T cells 
Numbers of memory T cells tend to increase with age, as a consequence 
of the response of TN cells to both foreign and self-Ags. Both CD8+ and 
CD4+ memory T cells undergo intermittent cell divisions once every 2-3 
weeks, which is paralleled by a balancing degree of cell death57. This 
turnover is largely MHC independent and relies on a combination of 
contacts with IL-7 and IL-15. First demonstrations regarding the factors 
involved in the control of memory T cells homeostasis date back to 1990s, 
where in vivo activation of the immune system caused by viral infections or 
injection of LPS or poly I:C without Ags reflected in a massive increase in 
the proliferation rate of both Ag-specific and bystander memory T cells58–
60. Specifically, production of Type I IFN increased after adjuvant 
stimulation, thus increasing IL-15 production by APCs, which in turn can 
directly stimulate memory T cells to elicit their proliferation59. As mentioned 
earlier, IL-15 (and IL-2) binds to CD122 and CD132, that are highly 
expressed on CD8+ memory T cells, less so on CD4+ memory T cells60. 
Work from Intlekofer et al demonstrated that CD122 expression is 
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regulated by T-bet and Eomes, two transcription factors that are 
upregulated upon T cell activation and differentiation61. In this work, 
Eomes+/-T-bet-/- mice displayed massive depletion of IL-15-dependent cell 
subsets, such as CD8+ memory T and NK cells, similarly to what occurs in 
IL-15-deficient mice, thereby linking the activity of transcription factors 
important for CD8+ effector T cell differentiation to survival61. IL-15 is 
extremely important for the survival of Ag-specific memory T cells. 
According to work from Ahmed and colleagues, a population of functional 
Ag-specific memory T cells is capable to develop in IL-15-deficient mice 
after lymphocytic choriomeningitis virus (LCMV) infection, but its total 
numbers was drastically reduced and then disappeared over time, thus 
showing that IL-15 is dispensable for the generation of Ag-specific 
memory T cells, but is necessary for their long term homeostatic 
proliferation62. 
Homeostasis of memory T cells relies on IL-7 as well as on IL-15. 
According to Kieper et al, overexpression of IL-7 in IL-15-deficient mice 
restored normal numbers of memory T cells, whereas background levels 
of IL-7 were not sufficient to sustain their generation and survival36.  
Work from Geginat and colleagues investigated how acquisition of several 
functions and phenotypical features of human CD8+ T cell subsets is 
affected by cytokine stimulation in vitro51. The authors showed that 
proliferative response to IL-7 was low in all subsets analysed, while 
response to IL-15 increased in parallel with progressive differentiation, as 
assessed by CFSE dilution. Further addition of IL-2 selectively stimulated 
memory T cells and provided additional boost to IL-7 and IL-15 
responses51, indicating that γc cytokines are not redundant, rather can act 
in concert to support effector T cell functions.  
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Homeostasis of memory CD4+ T cells is broadly similar to memory CD8+ T 
cells since they both need a combination of IL-7 and IL-15. However, there 
is a difference in terms of IL-7 and IL-15 usage: in fact, CD4+ memory T 
cells display lower expression of CD122, thus they are less IL-15-
dependent and their basal homeostatic proliferation requires both IL-7 and 
IL-1563. 
 
1.4  Heterogeneity of human TN cells 
TN cells have long been considered a largely homogeneous population64–
66. Nevertheless, the recent development of technological approaches 
capable to measure features at the single-cell level revealed heterogeneity 
in terms of response to antigen stimulation by individual TN cells. Work 
from Buchholz et al67 and Gerlach et al68 revealed that, in single-cell 
adoptive transfer or barcoding experiments in the context of mouse 
models of infection, individual CD8+ TN cells displayed different 
proliferation patterns. While some clones displayed massive proliferation, 
others proliferated at a lesser extent, and the entity of this proliferation 
positively correlated with effector versus memory differentiation67,68. Thus, 
single TN cells can behave differently in response to the same infectious 
stimulus. 
A different study from Tubo and colleagues obtained similar results for 
murine CD4+ T cells. Furthermore, this work demonstrated that TCR-
p:MHC-II dwell time or the antigen dose may play a role in differentiation 
divergence69.  
Additional studies on the murine TN cell repertoire revealed that the ability 
to respond to foreign antigens can be predicted by the level of cross-
reactivity to self-antigens. In both CD4+ and CD8+, increased TN cell 
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affinity for self Ags correlated with increased surface expression of CD570–
72. Accordingly, low and high expression of CD5 identified two TN cell 
populations, where CD5hi CD8+ TN are hyper-responsive to IL-2 and IL-7 
homeostatic cytokines 73 and have increased levels of genes involved in 
effector differentiation72 compared to CD5lo cells. In CD4+, CD5hi TN 
displayed enhanced TCR-dependent signaling potency70,71. Moreover, 
work from Alanio and colleagues proposed CD5 as a functional analogue 
for immune phenotypization of human TN cells in the context of chronic 
infection74. Indeed, they identified lower CD5 expression on CD8+ TN cells 
from patients with chronic HCV infection compared to healthy controls, 
and they correlated such reduced expression with a lower threshold for 
TCR signaling, which in turn brought to the accumulation of antigen-
inexperienced memory-phenotype T cells in this cohort, as proposed by 
the authors74. However, it is currently unclear whether CD5 marks distinct 
subsets of TN cells also in humans.  
 
1.5  T cell exhaustion and heterogeneity of exhausted T 
cells 
Persistent antigen stimulation via the TCR, as occurring in the context or 
chronic viral infections and cancer, induces a dysfunctional state, 
generally referred to as T cell exhaustion75, characterized by the 
acquisition of distinct gene expression and epigenetic programs, reduced 
effector capacity and proliferation, and augmented expression of inhibitory 
receptors including programmed cell death protein 1 (PD-1/CD279), 
lymphocyte-activation gene 3 (LAG3), T cell immunoreceptor with Ig and 
ITIM domains (TIGIT), 2B4/CD244, T cell immunoglobulin and mucin 
domain-containing protein 3 (TIM3) and cytotoxic T-lymphocyte antigen 4 
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(CTLA4)76. In the context of chronic viral infections, virus-specific T cells 
become progressively exhausted due to persistent Ag stimulation77. It is 
important to stress that these exhausted T cells (TEX) are not fully 
unresponsive as they are still capable to exert some effector functions, 
which are thought to be important to contain viral replication while 
reducing immune activation and thus immunopathology. In this regard, 
Frebel et al described fatal CD8 T cell-mediated immunopathology early 
after LCMV infection in mice lacking PD-1 signalling78. Thus, T cell 
exhaustion cannot be considered a fully dysfunctional state, rather a hypo-
responsive cell state, still capable to control pathology79. 
It has been recently proposed that TEX cells in chronic infections and 
cancer are characterised by substantial heterogeneity. Accordingly, Paley 
et al originally demonstrated that virus-specific CD8+ TEX are composed by 
a TbethiPD-1int progenitor which differentiates in an EOMEShiPD-1hi 
terminally differentiated, non-proliferating progeny80. Importantly, depletion 
of either subset resulted in the failure to control viral replication, thereby 
showing that both subsets play a central role80. Subsequently, several 
works investigated T-cell heterogeneity during chronic infections and 
described transcription factor TCF1 as a pivotal regulator of the generation 
of progenitors81–86. According to work from Ahmed and colleagues, TCF1+ 
CD8+ T, identified also as  PD-1+CXCR5+TIM3-, displayed a memory/stem 
cell-like phenotype and possessed capability to self-renew and to give rise 
to a TCF1lo/neg terminally differentiated progeny characterized by a PD-
1+CXCR5-TIM3+ phenotype82. These TCF1+ progenitors resulted capable 
to proliferate in response to inhibitory receptors blockade (PD-1/PD-L1) 
while TCF1- failed to do so, thus demonstrating that this memory/stem 
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cell-like population of progenitors constitutes the main effective target of 
immunotherapeutic treatments in chronic infections82.  
Additional studies in the context of cancer demonstrated that CD8+ tumor-
infiltrating T lymphocytes (TILs) possess exhaustion traits common to T 
cells in chronic viral infections, such as impaired production of effector 
cytokines and cytotoxic molecules, and increased expression of inhibitory 
receptors87. Recent work from our group identified TEX progenitors within 
the CD8+ infiltrate from non-small cell lung cancer patients, defined as 
CXCR5+TIM3-. Despite partially exhausted, as revealed by the 
overexpression of several inhibitory receptor molecules, these cells also 
expressed TCF1 and displayed memory-like hallmarks, such as IL-2 
production and enhanced self-renewal capacity compared to terminally-
differentiated CXCR5-TIM3+ cells88.  
Other recent studies identified TCF1+ TILs with memory/stem-like features 
and cytotoxic potential in human tumours84,89–91. In particular, Li et al 
combined TCR-sequencing with single-cell RNA-sequencing to 
demonstrate that TCF1+ TILs included bystander cytotoxic populations, 
while T cell clones specific for tumour Ags displayed a TCF1loPD-1+LAG3+ 
dysfunctional phenotype, and are characterized by CD39 expression, thus 
unveiling an additional layer of heterogeneity among human TILs92.  
CD8+ T cell subsets in human are characterized by specific epigenetic 
programs that dictate transcriptional, functional and phenotypical 
regulation93. Coherently, TEX cells displayed distinct patterns of chromatin 
accessibility compared to TN, TEFF and TMEM CD8+ T cells, characterized 
by the presence of differentially accessible regions in genes associated to 
inhibitory receptors and transcription factors associated to exhaustion89,94–
98. 
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Among transcription factors, recent work identified TOX as a central driver 
of the exhaustion program99–102 and found that TOX-deficiency in CD8+ T 
cells improves tumor control100,103. Overall, these studies support the 
notion that exhaustion in chronic infection and in cancer constitutes a 
separate branch of T cell differentiation with its own progenitors and 
terminally differentiated cells and characterized by a unique transcriptional 
and epigenetic identity. Whether a pre-commitment to this exhaustion 
program can be identified under physiological conditions is still unknown.  
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2  Aim of the study 
The CD8+ T cell compartment is highly heterogeneous in terms of 
phenotypes and functional capabilities, and the recent increased utilization 
of single cell techniques allowed a further investigation of such 
heterogeneity.  
In the murine CD8+ TN pool, CD5 allows the identification of functionally 
distinct subsets of TN cells with enhanced capability to respond to foreign 
antigens, suggesting that predetermined heterogeneity dictates the 
capacity and the magnitude of the immune response. Whether such 
functional heterogeneity is also present in the human CD8+ counterpart 
and can shape immune responses is still unknown. In the first part of this 
project, we evaluated the functional heterogeneity of the human CD8+ TN 
pool of healthy individuals. Specifically, we used flow cytometry and cell 
sorting for the characterization and isolation of discrete subsets of human 
CD8+ TN subsets, as well as molecular technologies, functional assays 
(both in vitro and in vivo) and RNA sequencing to obtain an all-
encompassing characterization of the identified populations. 
In the second part of the work, we aimed to characterize the stem-like pool 
of CD8+ T cells in light of the recent discoveries of stem-like progenitors 
with distinct traits in cancer and chronic viral infections. We hypothesized 
that differentiation of these progenitors could occur in physiology in 
healthy individuals. We applied un unbiased approach guided by single-
cell RNA sequencing to identify candidate memory progenitor subsets. We 
then performed cellular and molecular assays to characterize such 
progenitors at the functional, transcriptional and epigenetic level, in order 




Results indicated as “part 1” are included in De Simone et al., J Immunol, 
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subsets of stem-like CD8+ memory T cell progenitors with distinct fate 
commitments in humans. Nat. Immunol. 21, 1552–1562 (2020).105 
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3  Materials and methods 
3.1  Cells 
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy 
coats from healthy donors by Ficoll gradient separation and used fresh for 
most of the assays. In some cases, PBMCs, previously frozen in liquid 
nitrogen in a suspension containing FBS+10% DMSO, were used. 
Surgically-removed lymph nodes were isolated as previously described106. 
Total CD8+ T cells or naïve CD8+ T cells were enriched by magnetic 
separation by using EasySep™ Human CD8+ T Cell Isolation Kit (Stem 
Cell Technologies) or MojoSort Human CD8+ Naive T Cell Isolation Kit 













Sex (no.) female 12
male 42
unknown 4
Age (yr.) mean ± SD 40 ± 13
range min - max 23 - 73
unknown (no.) 10
Condition (no.) healthy (PB) 54
head and neck cancer patients** 4
Parameter Subdivision
Sex (no.) female 24
male 95
unknown 1
Age (yr.) mean ± SD 50 ± 11
range min - max 22 - 77
unknown (no.) 3
Condition (no.) healthy (PB) 100
HIV+ (PB) 2
non-small cell lung cancer patients* 6
head and neck cancer patients** 6
healthy bone marrow donors*** 6
Cohort of samples (1st part)
Cohort of samples (2nd part)
Table 1: Donors used in the study. Abbreviations: no.= number, yr.= years, SD= standard 
deviation. *donating PB and a tumor-free lung sample, **donating PB and a tumor-free lymph 
node, ***donating PB and bone marrow 
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3.2  Flow cytometry and cell sorting 
Fluorochrome-conjugated monoclonal antibodies were purchased from BD 
Biosciences, BioLegend and eBioscience, and titrated to determine 
optimal concentrations107. Chemokine receptors expression was 
measured by incubating cells at 37°C for 20 min. Surface markers were 
measured by incubating cells at RT for 20 min. The Cytofix/Cytoperm kit 
(BD Biosciences) was used to detect intracellular cytokine expression. In 
all assays, cells were stained for 15 min at room temperature with Zombie 
Aqua fixable viability die to remove dead cells (BioLegend). TNR3– and 
TNR3+ were FACS-sorted according to the gating strategy depicted in Fig 
2A. TPEX and TSTEM were FACS-sorted according to the gating strategy 
depicted in Fig19C.  
 
All samples were acquired on LSR Fortessa or FACSSymphony A5 flow 
cytometers or separated via a FACSAria III cell sorter (all from BD 
Biosciences). Flow cytometry data were analyzed and  






































































Figure 2: Gating strategy for the identification and FACS sorting of the cell 
subsets in the first part 
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compensated with FlowJo 9 (FlowJo LLC) by using single-stained controls 







Figure 3: Gating strategy for the identification and FACS sorting of the cell subsets in 
the second part 
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ANTIBODY FLUOROCHROME CLONE SOURCE IDENTIFIER RRID
Anti-human CD3  PE-Cy5 UCHT2 BD Biosciences Cat # 555341 RRID:AB_395747
Anti-human CD5 BV605 UCHT2 BD Biosciences Cat-# 563945 RRID:AB_2738500
Anti-human CD27 FITC M-T271 BD Biosciences Cat # 555440 RRID:AB_395833
Anti-human CD27 APC efluor780 O323 eBioscience Cat # 47-0279-42 RRID:AB_1272040
Anti-human CD45RA BV421 HI-100 BD Biosciences Cat # 562885 RRID:AB_2737864
Anti-human CD45RO PerCP-Cy5.5 UCHL1 Biolegend Cat # 304222 RRID:AB_2174124
Anti-human CD73 BV605 AD2 BD Biosciences Cat # 563199 RRID:AB_2738063
Anti-human CD95 PE-Cy5 DX2 BD Biosciences Cat # 559773 RRID:AB_397317
Anti-human CD4 BV570 RPA-T4 Biolegend Cat # 300534 RRID:AB_2563791
Anti-human CXCR3 PE G025H7 Biolegend Cat # 353706 RRID: AB_10962912
Anti-human CXCR3 BV711 G025H7 Biolegend Cat # 353732 RRID:AB_2563533
Anti-human CXCR3 BV711 1C6 BD Biosciences Cat # 563156 RRID:AB_2738034
Anti-human CXCR3 AF647 G025H7 Biolegend Cat # 353712 RRID:AB_10962948
Anti-human CD95 BV605 DX2 Biolegend Cat # 305627 RRID:AB_2562444
Anti-human CD45RA () FITC ALB11 Beckman Coulter Cat # A07786 N/A
Anti-human CD4  () PE-Cy5 13B8.2 Beckman Coulter Cat # A07752 N/A
Anti-human CD19 PE-Cy5 J3-119 Beckman Coulter Cat # A07771 N/A
Anti-human CD56 PE-Cy5 N901 Beckman Coulter Cat # A07789 N/A
Anti-human TNF-α PE MAb11 eBioscience Cat # 12-7349-81 RRID:AB_466207
Anti-human IFN-γ APC-Cy7 4S.B3 Biolegend Cat # 502530 RRID:AB_10663412
Anti-human Perforin APC B-D48 Biolegend Cat # 353312 RRID:AB_2571969
Anti-human Granzyme B Pacific Blue GB11 Biolegend Cat # 515408 RRID:AB_2562196
Anti-human MIP-1α PE CR3M eBioscience Cat # 12-9706-41 RRID:AB_2572721
Anti-human MIP-1β AF700 D21-1351 BD Biosciences Cat # 561278 RRID:AB_10612008
Anti-human CD127 PE hIL-7R-M21 BD Biosciences Cat # 557938 RRID:AB_2296056
Anti-human CCR7 BV421 G043H7 Biolegend Cat # 353208 RRID:AB_11203894
Anti-human CD45 PE-Cy7 HI30 BioLegend Cat # 304016 RRID:AB_314404
Anti-human CD8 BUV 805 SK1 BD Biosciences Cat # 564912 RRID:AB_2744465
Anti-human CD8 BV786 RPA-T8 BD Biosciences Cat # 563823 RRID:AB_2687487
Anti-human CD4 FITC M-T477 BD Biosciences Cat # 556615 RRID:AB_396487
Anti-human CCR7 BV711 G043H7 BioLegend Cat # 353228 RRID:AB_2563865
Anti-human CD45RA BV480 HI100 BD Biosciences Cat # 566114 RRID:AB_2739516
Anti-human CD45RO APC-H7 UCHL1 BD Biosciences Cat # 561137 RRID:AB_10562194
Anti-human CCR7 BB660 150503 BD Biosciences Cat # 625454 N/A
Anti-human CD95 BV421 DX2 BioLegend Cat # 305624 RRID:AB_2561830
Anti-human CD95 BUV563 DX2 BD Biosciences Cat # 624284 N/A
Anti-human CD95 APC DX2 BD Biosciences Cat # 558814 RRID:AB_398659
Anti-human CD45RO BUV395 UCHL1 BD Biosciences Cat # 562491 N/A
Anti-human CD3 BV650 OKT3 BioLegend Cat # 317324 RRID:AB_2563352
Anti-human CD4 BV570 RPA-T4 BioLegend Cat # 300534 RRID:AB_2563791
Anti-human CD4 BUV615 SK3 BD Biosciences Cat # 624297 N/A
Anti-human CD3 BUV496 UCHT1 BD Biosciences Cat # 564809 RRID:AB_2744388
Anti-human CD27 BV570 O323 BioLegend Cat # 302825 RRID:AB_11149686
Anti-human TNF-α APC-Cy7 mAB11 BioLegend Cat # 502944 RRID:AB_2562870
Anti-human IFN-γ PE-Cy7 B27 BioLegend Cat # 506518 RRID:AB_2123321
Anti-human IL-2 APC MQ1-17H12 BD Biosciences Cat # 554567 RRID:AB_398571
Anti-human CD45 Pacific Blue HI30 BioLegend Cat # 304022 RRID:AB_493655
Anti-human CD3 PE-Cy5 HIT-3A BD Biosciences Cat # 555341 RRID:AB_395747
Anti-human CCR7 PE-CF594 150503 BD Biosciences Cat # 562381 RRID:AB_11153301
Anti-human CD27 PE M-T271 BD Biosciences Cat # 560985 RRID:AB_10563213
Anti-human CD28 BV785 CD28.2 BioLegend Cat # 302950 RRID:AB_2632607
Anti-human CD25 APC-R700 2A3 BD Biosciences Cat # 565106 RRID:AB_2744339
Anti-human CD69 BUV737 FN50 BD Biosciences Cat # 564439 RRID:AB_2722502
Anti-human CD107a PE-Cy5 H4A3 BD Biosciences Cat # 555802 RRID:AB_396136
Anti-human CD107a BB630 H4A3 BD Biosciences Cat # 624294 N/A
Anti-human CD127 PE-Cy5 eBioRDR5 eBioscience Cat # 15-1278-42 RRID:AB_2043801
Anti-human PD-1 BV480 EH12.1 BD Biosciences Cat # 566112 RRID:AB_2739514
Anti-human PD-1 PE-Cy7 EH12.2H7 BioLegend Cat # 329918 RRID:AB_2159324
Anti-human TIGIT PerCP-eFluor 710 MBSA43 eBioscience Cat # 46-9500-42 RRID:AB_10853679
Anti-human TIGIT FITC MBSA43 eBioscience Cat # 11-9500-41 RRID:AB_2572529
Anti-human TIGIT BV421 A15153G BioLegend Cat # 372710 RRID:AB_2632925
Anti-human HLA-DR BUV661 G46-6 BD Biosciences Cat # 565073 RRID:AB_2722500
Anti-human CD38 BV711 HIT2 BioLegend Cat # 303528 RRID:AB_2563811
Anti-human CD103 BV421 Ber-ACT8 BioLegend Cat # 350213 RRID:AB_2563513
Anti-human CD161 BV605 HP-3G10 BioLegend Cat # 339916 RRID:AB_2563607
Anti-human CD14 BV510 M5E2 BioLegend Cat # 301842 RRID:AB_2561946
Anti-human Granulysin Alexa Fluor 488 RB1 BD Biosciences Cat # 558254 N/A
Anti-human EOMES PE-eFluor 610 WD1928 eBioscience Cat # 61-4877-41 RRID:AB_2574615
Anti-human Granzyme B APC-R700 GB11 BD Biosciences Cat # 561016 RRID:AB_2033973
Anti-human Granzyme K PE GM6C3 Santa Cruz Cat # sc-56125 PE RRID:AB_2263772
Anti-human Granzyme K Alexa Fluor 647 GM6C3 Santa Cruz Cat # sc-56125 AF647RRID:AB_2263772
Anti-human IRF4 Alexa Fluor 488 IRF4.3E4 BioLegend Cat # 646406 RRID:AB_256326
Anti-human IRF8 APC V3GYWCH eBioscience Cat # 17-9852-80 RRID:AB_2573317
Anti-human T-bet PE-Cy7 4-B10 eBioscience Cat # 25-5825-82 RRID:AB_11042699
Anti-human LEF1 PE C12A5 Cell Signaling Cat # 14440 N/A
Anti-mouse CD45.1 PE-Cy7 A20 BD Biosciences Cat # 560578 RRID:AB_1727488
Anti-mouse CD45 PerCP-Cy5.5 30-F11 BioLegend Cat # 103132 RRID:AB_893340
Anti-mouse CD45.1 BV605 A20 Biolegend Cat # 110738 RRID:AB_2562565
Anti-mouse CD45.2 APC-Cy7 104 Biolegend Cat # 109824 RRID:AB_830789
Anti-mouse CD8 BV570 53-6.7 Biolegend Cat # 100740 RRID:AB_2563055
Anti-mouse CD62L APC MEL-14 BD Biosciences Cat # 553152 RRID:AB_398533
Anti-mouse CD44 FITC IM7 eBioscience Cat # 11-0441-82 RRID:AB_465045
Anti-mouse CD3 BV650 145-2C11 BD Biosciences Cat # 564378 RRID:AB_2738779
Anti-mouse CD127 BV786 SB/199 BD Biosciences Cat # 563748 RRID:AB_2738403
Anti-mouse KLRG1 BV421 2F1/KLRG1 Biolegend Cat # 138414 RRID:AB_2565613
Anti-mouse CXCR3 PE CXCR3-173 Biolegend Cat # 126506 RRID:AB_1027650
Table 2: List of Flow Cytometry antibodies used in the study 
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3.3  Age-associated changes of TN cell subsets 
TNR3– and TNR3+ cells were quantified in a cohort of 1,938 individuals 
from the general population (815 males and 1123 females), aged 19-105, 
belonging to the SardiNIA Study108,109. Immunophenotyping was carried 
out by flow cytometry on fresh blood samples. To avoid circadian 
fluctuations and time dependent artefacts, blood samples were collected in 
heparin tubes at 8 am and immune-phenotypes were performed in the 
same recruitment center within two hours from the withdrawal. Blood was 
then antibody-stained, erythrocyte lysed and acquired with a FACSCAriaIII 
analyzer (BD Biosciences). CXCR3+ T cells were quantified in the naïve-
like CD8 population, defined as CD3+CD4–
CD45RA+CCR7+CD127+CD161–PD-1–. 
 
3.4  Cell culture 
Cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 
1% penicillin/streptomycin and 2mM L-glutamine (hereafter referred to as 
R10). To induce cytokine production, FACS-sorted TNR3– and TNR3+ and 
total PBMCs were stimulated in a final volume of 200 µL with phorbol 12-
myrystate 13-acetate (PMA; 10 ng/mL) and ionomycin (500 ng/mL) (both 
from SigmaAldrich) for 6 hours in the presence of the protein transport 
inhibitors GolgiPlug (1µL/mL of cell culture, BD Biosciences) and 
GolgiStop (0.67µL/mL of cell culture, BD Biosciences), according to 
manufacturer’s instructions. 
Cells were also stimulated or not with Staphylococcus Enterotoxin-B (SEB; 
1μg/mL; SigmaAldrich) overnight. To evaluate differentiation and 
proliferation capability, cells were stimulated with anti-CD3/CD28 
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activation beads (Dynabeads; Thermo Fisher Scientific) in combination 
with cocktail of human cytokines, according to experimental design. 
Human cytokines for cell cultures (Peprotech) were pre-titrated and then 
used at 10 ng/ml (TGF-β, IL-2, IL-12, IL-7, IL-15) for 3 to 4 days. To 
evaluate memory maintenance in response to homeostatic cytokines, cells 
were stimulated with IL-15 alone (25 ng/ml) for 10 days. 
 
3.5  Quantification of TRECs 
TNR3–, TNR3+, TSCM and bulk CD45RO+ memory T cells were FACS-
sorted in PBS without Ca2+ and Mg2+ (PBS–/–) then washed twice in PBS–/– 
and frozen at -80°C. After thawing, cells were lysed in a Proteinase K 
solution (Roche; 100 µg/mL diluted in 10mM Tris-HCl pH8; 10µL/100000 
cells). TREC content was determined by quantitative real-time PCR, as 
previously described110, and normalized to the number of cells contained 
in each sample, determined via quantification of FAS.  
 
3.6  Quantification of gene expression via qPCR 
Total RNA, purified with RNeasy Micro Kit (Qiagen) with DNAse (Qiagen), 
was retro-transcribed using High capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) and analyzed by qPCR with hydrolysis probes 
CXCR3 (Hs00171041_m1). Quantification of B2M (Hs00187842_m1) 
served as reference gene. qPCR was performed with Universal PCR 
Master Mix, No Amperase UNG (Roche) in MicroAmp Fast Optical 96-Well 
reaction Plate (Applied Biosystems) on the ABI 7900HT Sequence 
Detection System (Applied Biosystems). Expression levels were 
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normalized (DCt) to B2M endogenous control according to the formula 2-(Ct 
CXCR3–Ct B2M). 
 
3.7  Enumeration of antigen-specific CD8+ T cells by MHC 
class I tetramers 
Biotinylated HLA-A*0201/CMV pp65495-503 NLVPMVATV (NV9), HLA-
A*0201/Flu matrix protein58-66 GILGFVFTL (GL9), HLA-A*0201/MART-126-
35 ELAGIGILTV, and HLA-A*0201/CMV KA227/8 NLVPMVATV (KA) 
monomers were multimerized with streptavidin-BV421 (Sigma), PE 
(Sigma) and APC (Life Technologies), as previously described111. Cells 
were stained for 15 min at 37°C (1 µg tetramer in 100 µl). On average, 
6x106 PBMCs were acquired by flow cytometry. 
 
3.8  Enumeration of antigen-specific TN cell precursors by 
libraries of amplified T cells 
Peripheral Blood Mononuclear Cells (PBMCs) were isolated with Ficoll-
Paque Plus (GE Healthcare). Monocytes and total CD8+ T cells were 
isolated by positive selection using CD14 and CD8 magnetic microbeads, 
respectively (Miltenyi Biotech). Two subsets of CD8+ CD45RA+ CCR7+ 
CD27+ CD95– CD4– CD19– CD56– naïve T cells were sorted from total 
CD8+ T cells with a FACS Aria, on the basis of CXCR3 expression. 
Memory CD8+ T cells were sorted as control subset. 
T cells were cultured in RPMI 1640 medium supplemented with 2 mM 
glutamine, 1% (vol/vol) nonessential amino acids, 1% (vol/vol) sodium 
pyruvate, penicillin (50 U/ml), streptomycin (50 µg/ml) (all from Invitrogen) 
and 5% human serum (Swiss Red Cross). The sorted T cells (2,000 
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cells/well) were polyclonally stimulated with 1 µg/ml PHA (Remel) in the 
presence of irradiated (45Gy) allogeneic feeder cells (2.5 × 104 per well) 
and IL-2 (500 IU/ml), in a 96-well plate. T cell lines were expanded as 
previously described112. Library screening was performed 14-21 days after 
initial stimulation, by culturing thoroughly washed T cells (2.5 × 105/well) 
with autologous irradiated B cells (2.5 × 104), with or without a three-hour 
pulse with different antigens. The antigens used included the HIV-1 
peptide pool (1 µg/ml/peptide, comprising 386 18-mer peptides spanning 
the entire 2004 consensus clade C HIV-1 proteome), the Zika virus 
H/PF/2013 peptide pool (1 µg/ml/peptide, comprising 669 10-mer peptides 
spanning Env, NS3 and NS5 proteins), the human cytomegalovirus (CMV) 
peptide pool (1 µg/ml/peptide, from A. Sette’s laboratory, La Jolla Institute 
for Immunology, comprising 198 peptides of length 8-11aa), the Epstein–
Barr virus (EBV) peptide pool (1 µg/ml/peptide, from A. Sette’s laboratory, 
LJI, comprising 218 peptides of length 8-11aa), the Influenza A virus 
A/California/07/2009 (H1N1) peptide pool (2 µg/ml/peptide, comprising 
351 15-mer peptides spanning Hemagglutinin, Neuraminidase, Matrix 
protein 1 and Nucleoprotein). Proliferation was assessed on day 4, after 
incubation for 16 h with 1 µCi/ml [methyl-3H]thymidine (Perkin Elmer). 
Precursor frequencies were calculated based on numbers of negative 






3.9  Antigen-specific T cell proliferation and effector 
functions 
CMV seronegative buffy coat donors were identified by coating plates with 
2 µg/ml sonicated HCMV, followed by ELISA detection of plasma IgGs. 
Sorted TNR3–, TNR3+ and TMEM CD8+ T cells from these donors were 
labeled with CFSE and cultured at a ratio of 2:1 with irradiated autologous 
monocytes pre-pulsed for 5h with human CMV lysate or seasonal 
influenza virus vaccine (Influvac 2017/2018, from Mylan) together with 
CMV peptide pool or Influenza A Matrix protein 1 peptide pool, 
respectively. On day 10, T cells were stimulated with PMA and ionomycin 
for 5h in the presence of brefeldin A for the last 2h (all reagents from 
Sigma-Aldrich). Cell viability was determined by staining with LIVE/DEAD 
Fixable Aqua Dead Cell Stain Kit (ThermoFisher), according to the 
manufacturer’s instructions. Subsequently cells were fixed and 
permeabilized with Cytofix/Cytoperm (BD Biosciences), and then stained 
for flow cytometric analysis.  
 
3.10  TCR deep sequencing and data analysis 
TNR3–, TNR3+ and CD45RO+ TMEM were FACS-sorted in triplicate (300,000 
cells/subset) in 1.2 mL RLT buffer (Qiagen; final dilution <20%). TPEX, 
TSTEM and TEM were FACS-sorted in duplicate (150,000 cells/subset). RNA 
was extracted using RNeasy mini kit (Qiagen) according to the 
manufacturer protocol. Unique molecular identifier (UMI)-labelled 5’RACE 
TRB cDNA libraries were prepared using Human TCR Profiling Kit 
(MiLaboratory LLC). All extracted RNA was used for cDNA synthesis, and 
all synthesized cDNA was used for PCR amplification. Libraries were 
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prepared in parallel using the same number of PCR cycles and sequenced 
150+150 bp on Illumina NextSeq. We obtained about 135 mln TRB 
sequencing reads (1.5 mln  ± 0.3 mln reads per library), from which about 
4 mln unique UMI-labelled TRB cDNA molecules (53,000  ± 10,000  
molecules per library) were extracted using MIGEC113 and MiXCR114  
 software with MIGEC threshold set as at least 2 sequencing reads per 
UMI. Each library contained an average of 40,000±10,000 functional (in-
frame, without stop-codons) CDR3 nucleotide sequence variants (unique 
TRBβ clonotypes). Averaged physico-chemical characteristics of 5 amino 
acid residues located in the middle of TRBβ CDR3 (weighted by clonotype 
size) were analyzed using VDJtools software115. In particular, we analyzed 
averaged statistical potential of CDR3:epitope interactions (the estimated 
“energy” of interaction between CDR3 and peptide116, “strength” of 
interaction (derivative of “energy”), hydrophobicity (Kidera factor 4)117,118, 
and “volume” indexes. Diversity metrics were analyzed by VDJtools after 
downsampling to the same number of 5,000 (first project part) and 3,000 
(second project part) randomly selected UMI-labeled TRB cDNA 
molecules per sample. 
 
3.11  Gene expression profiling by DNA microarrays and 
data analysis 
Sorted TNR3–, TNR3+ and CD45RO+ TMEM cells were washed twice in 
PBS–/–, resuspended in RLT buffer (Qiagen), processed and analyzed as 
previously described119. Briefly, microarray probe fluorescence signals 
were converted to expression values using robust multiarray average 
(RMA) procedure120 of Bioconductor Affy package. Specifically, 
fluorescence intensities were background adjusted and normalized using 
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quantile normalization. Log2 expression values for a total of 32,500 custom 
probe sets were calculated using median polish summarization and 
custom chip definition files for Affymetrix Human Transcriptome Array 2.0 
based on Entrez genes (hta20_Hs_ENTREZG version 21.0.0). All data 
analyses were performed in R version 3.4.4. Differentially expressed 
genes between human TNR3– and TNR3+ cells were identified by the 
limma algorithm coded in the same R package121. 
 
3.12  Pathway analysis of microarray data 
Pathway analysis was performed using GSEA software 
(http://software.broadinstitute.org/gsea/msigdb/) and gene sets from 
Molecular Signatures Database (Version 6.2). Namely, we used gene sets 
of the c2 (c2.cp.reactome.v6.2) and immunological signatures (c7.all.v6.2) 
collections. GSEA was applied on log2-transformed expression data of 
TNR3– and TNR3+ cells. Prior to this analysis, mouse gene IDs obtained 
from the comparison between TNR3+ vs. CD5lo or CD5hi cells were 
converted into the corresponding human orthologue genes using the 
HUGO Gene Nomenclature Committee (HGNC) database 
(https://www.genenames.org/cgi-bin/hcop). Gene sets were considered 
significantly enriched at FDR≤0.05 when using Signal2Noise as metric and 
1,000 permutations of the gene sets. 
 
3.13  Mice 
Animal protocols were approved by the Humanitas IACUC and by the 
Italian Ministry of Health (No. 452/2018-PR), and by the San Raffaele 




3.14  Mouse CD8+ TN cell sorting and RNAseq 
Spleens from C57BL/6 male mice (Charles River Laboratories) were 
collected at 12 weeks of age and mechanically smashed by plunger of a 2 
ml syringe with a 40 μm cell strainer. Splenocytes were enriched for CD8+ 
T cells with the MojoSort mouse CD8+ T cell isolation kit (Biolegend) and 
stained for FACS. FACS-sorted cells were lysed with 50 µL RLT buffer 
(Qiagen), with the addition of 1 µL RNAse inhibitor (Qiagen). RNA 
extraction was performed with the RNeasy Micro Kit (Qiagen), according 
to the manufacturer’s instructions. RNAseq libraries were prepared by 
using the SMARTseqv4 RNA kit for sequencing (Clontech-Takara) which 
is designed to generate high-quality, full-length cDNA directly from 10 pg 
to 10 ng of total RNA. This Kit incorporates Clontech’s proprietary 
SMART® (Switching Mechanism at 5’ End of RNA Template) technology. 
This technology relies on the template switching activity of reverse 
transcriptases to enrich for full-length cDNAs and to add defined PCR 
adapters directly to both ends of the first-strand cDNA. This ensures the 
final cDNA libraries contain the 5’ end of the mRNA and maintain a true 
representation of the original mRNA transcripts; these factors are critical 
for transcriptome sequencing and gene expression analysis. Libraries 
have been pooled at equimolar concentrations and sequenced on an 
Illumina NextSeq 500 platform; at least 20 million 75bp single end reads 





3.15  RNAseq data analysis 
After quality control with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc), 75-bp single-
end reads were aligned to the Mus musculus reference genome (Ensembl 
assembly GRCm38) using STAR (version 2.5.1b)122. Alignment was 
performed with default parameters, and reads associated to annotated 
genes were counted with HTSeq and “-quantmode TranscriptomeSAM 
GeneCounts” options. Differential expression between murine TN subsets 
was assessed using the edgeR package (version 3.22)123 
applying Benjamini-Hochberg multiple testing correction to estimate the 
FDR.  
 
3.16  In vivo studies 
LCMV-P14 TCR transgenic mice were obtained through the Swiss 
Immunological Mutant Mouse Repository (Zurich, Switzerland). CD8+ TN 
cell subsets from CD45.1 LCMV P14 mice (kept in SPF conditions) were 
isolated as described above. 1-2x104 cells were injected i.v. into CD45.2 
WT recipient animals (C57BL/6) 16 hours prior i.v. infection with 2x105 
FFU of LCMV Armstrong. Animals were sacrificed at day 7 and 14 after 
infection, single cell suspensions were obtained from spleens and stained 
for flow cytometry as described above. 
For in vivo persistence experiments,  Eight-week-old female JAX NOD.Cg-
Prkdcscid Il2rgtm1Wjl/SzJ (NSG, #005557, Charles River) mice were infused 
by retroorbital injection with TSTEM, TMEX or TEM cells (1x106 per mouse), 
freshly sorted from healthy donors’ PBMCs (n=2). A third experiment was 
excluded from the analysis due to poor recovery of cells following transfer 
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in primary recipients. Autologous CD8–  PBMCs (6x106 per mouse) were 
co-injected as support. Blood sampling from the lateral tail vein was 
performed at 11, 18 and 28 days post transfer to monitor T cell 
engraftment and expansion. Mice were sacrificed at day 28. Spleens were 
collected from mice, processed to single cell suspension and the number 
of human T cells was determined. Absolute numbers of T cells in the blood 
was determined by CountBright Absolute Counting Beads (Invitrogen), 
according to manufacturer’s protocol. The frequency of human CD4+ and 
CD8+ T cell subsets was determined by flow cytometry. To maximize the 
recovery of human T cells, spleens and lungs from the same experimental 
group were mixed, the CD4:CD8 ratio of TSTEM and TMEX normalized with 
autologous CD8– PBMCs and injected as above in secondary NSG 
recipients (1x106 CD8+ T cell per mouse). TEM cells could not be 
transferred due to low cell recovery. Expansion and absolute numbers of T 
cells were monitored as mentioned above. 
For tumor experiments, cell were transduced as follows: T cell subsets 
were FACS-sorted from total PBMCs of one healthy donor. CD3+ T cells, 
used as a control, were purified by magnetic separation. T cells were 
stimulated with the MACS-GMP T Cell TransAct cocktail (Miltenyi), 
transduced on day 1 with a bidirectional lentiviral vector encoding a CD19 
CAR harboring CD28 costimulus in sense and the LNGFR marker gene in 
antisense, and finally kept in culture for 13 days in TexMacs medium 
(Miltenyi) supplemented with 3% FBS, 1% penicillin/streptomycin and IL-
7/IL-15 (Miltenyi). Eight-week-old female NSG mice were intravenously 
injected with 0.5x106 Lucia+/NGFR+/NALM-6 cells, followed 4 days later by 
injection of 3x106 CAR19-redirected TSTEM, TMEX or total CD3+ T cells. 
Untransduced CD3+ T cells were used as controls. Tumor progression 
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was monitored weekly by bioluminescence detection by using the 
QUANTI-Luc detection reagent (InvivoGen) and expressed as relative light 
units (RLUs), according to the manufacturer’s instructions. 
 
3.17  tSNE analysis of high-dimensional CyTOF data 
Public CyTOF data of T cell antigen expression from tonsils, spleen, liver, 
gut, skin and lung were previously described in Wong et al.124 and were 
downloaded from https://flowrepository.org/. Files (debarcoded samples) 
were imported in FlowJo and concatenated into a single .fcs file (~2,500 
events/sample) which was subsequently subjected to t-SNE analysis 
(Barnes-Hut implementation) with the following parameters: iterations, 
1000; perplexity, 40; initialization, deterministic; theta, 0.5; eta: 200. All 
markers listed in Fig 3A , except CXCR3, were included in the analysis.  
 
3.18  Single-cell RNA sequencing 
100,000 FACS-sorted CD95+CD8+ T cells from four healthy donors were 
resuspended in 1 ml PBS–/– plus 0.04% BSA and washed two times by 
centrifugation at 450 rcf for 7 min. After the second wash, cells were 
resuspended in 100 µL and counted with an automatic cell counter 
(Countess II, Thermo Fisher) to get a precise estimation of total number of 
cells recovered. Afterwards, about 20,000 cells of each sample were 
loaded into one channel of the Single Cell Chip A using the Single Cell 3’ 
v2 reagent kit (10X Genomics) for Gel bead Emulsion generation into the 
Chromium system. Following capture and lysis, cDNA was synthesized 
and amplified for 14 cycles by following the manufacturer’s protocol (10X 
Genomics). 50 ng of the amplified cDNA for each sample were then used 
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to construct sequencing libraries. Sequencing was performed on the 
NovaSeq 6000 Illumina system following 10X Genomics instruction for 
reads generation. An average sequencing depth of at least ~50,000 
reads/cell was obtained for each sample. 
 
3.19  Single-cell RNA sequencing analysis 
Sample demultiplexing, barcode processing and UMI counting were 
performed by using the 10x Genomics pipeline Cell Ranger v2.1.1 
(https://support.10xgenomics.com). Briefly, raw base call files were 
demultiplexed in FASTQ format using the “cellranger mkfastq” pipeline. 
Then, cellranger count was run with --transcriptome=refdata-cellranger-
GRCh38-1.2.0 for each sample. The outputs of cellranger count for 
individual samples were concatenated into one matrix and the libraries 
were normalized to the same sequencing depth using the “cellranger aggr” 
pipeline. The concatenated gene-cell barcode matrix was loaded into R by 
using the Seurat package125. To exclude genes that might be detected 
from random noise, we filtered genes whose expression was detected in 
less than three cells, and retained cells where at least 200 features were 
detected. Moreover, we considered outliers and filtered out cells if they 
had unique feature counts over 3,500 or less than 200 and more than 10% 
of mitochondrial counts. The resulting dataset was normalized through a 
global-scaling method, converted by a scale factor (10,000 by default) and 
log-transformed using the “ScaleData” Seurat implemented function. The 
resulting data were subjected to clustering analysis using standard Seurat 
package procedures. In particular, the first 20 principal components and a 
resolution equal to 0.6, were used to cluster the cells into subpopulations 
through a graph-based unsupervised clustering approach implemented in 
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Seurat (“FindClusters” function). Differentially expressed genes of each 
single cluster compared to all other cells were identified using the 
“FindAllMarkers” function. All markers distinguishing cluster 2 from cluster 
6, were identified by using the “FindMarkers” function coded in Seurat 
package. 
 
3.20  High-dimensional flow cytometry data analysis 
Flow Cytometry Standard (FCS) 3.0 files were imported into FlowJo 
software version 9, analyzed by standard gating to remove aggregates 
and dead cells, and CD95+ bulk memory CD8+ T cells were identified. 
5,000 CD95+ T cells per sample were subsequently imported in FlowJo 
version 10, biexponentially transformed and exported for further analysis 
in Python (version 3.7.3) by a custom-made script that makes use of 
PhenoGraph (originally retrieved from the scikit-learn package; full script 
available at https://github.com/luglilab/Cytophenograph). Lymph nodes, 
bone marrow and adjacent cancer-free lung tissues were labelled with a 
unique computational barcode for further identification and converted in 
comma separated (CSV) files and concatenated in a single matrix by 
using the merge function of pandas package. K value, indicating the 
number of nearest neighbors identified in the first iteration of the algorithm, 
was set equal to 1000 for clustering. UMAP was obtained by UMAP 





3.21  Cytometry by Time of Flight (CyTOF) antibody and 
streptavidin labeling 
Antibodies were labelled by following MAXPAR conjugation protocol 
available from Fluidigm. Antibodies were titrated for optimal concentrations 
before staining of donor samples. Streptavidin was expressed, refolded, 
and purified in-house, then labelled as described126. 
 
3.22  Preparation of peptide-MHC monomers 
Myc-tagged HLA-A*02:01 was synthesized, refolded with appropriate UV-
cleavable peptide, and biotinylated as described127. Biotinylated HLA-
A*0201 with a UV-cleavable peptide was diluted to 100 µg/mL in PBS and 
mixed with 5 µL of 1 mM peptide for a total of 100 µL per reaction. 
Reactions were exposed to long-wave UV light (368 nm) for 5 mins in a 
Fisher UV Crosslinker, then rotated 180 degrees and exposed again. Plate 
was incubated overnight at 4o C before tetramerization the next day. 
 
3.23  Mass cytometry staining with combinatorial peptide-
MHC tetramers and magnetic bead enrichment 
Heavy-metal labelled streptavidin were mixed together according to a 
triple coding scheme as previously described (20 µL of 50 µg/mL dilution 
for a total of 60 µL per combination) (Ref 51, 52 paper). Combined 
streptavidin were then added to the peptide-MHC monomers, prepared as 
described above, in 3 separate additions of 20 µL with 5 minutes of 
incubation time in between each addition. Tetramerized peptide-MHC 
were then combined in a 50 kDa Amicon concentrator (Millipore) and 
concentrated at 4000xG, then diluted to 200 µL per donor and filtered 
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through a 0.1 micron Amicon centrifugal filter (Millipore). Cryopreserved 
PBMCs for three healthy donors and two HIV seropositive donors were 
obtained from HVTN in advance and thawed at 37oC before transferring 
into RPMI, then FACS buffer (0.5% BSA, 0.02% sodium azide in PBS). 
Cells were stained for one hour with tetramer cocktail at room 
temperature, along with CCR5, CCR7, TIGIT, PD-1, and CXCR5 to 
improve staining quality. Tetramer cocktail was washed off with MACS 
buffer (0.5% BSA, 2 mM EDTA), and ~2 million cells were separated as 
pre-enriched fractions. The remaining cells were incubated with a 1:3 
dilution of anti-c-myc magnetic beads (Miltenyi Biotec) on ice for twenty 
minutes, then magnetically enriched. LS magnetic columns (Miltenyi 
Biotec) were washed with 2 mL MACS buffer, followed by application of 
cells. Flowthrough was collected with 3x2mL washes before magnetic 
columns were removed from the magnetic field and enriched cells were 
collected by washing the column with 5 mL of MACS buffer and a plunger. 
Cell numbers were counted and, when applicable, enriched fractions were 
supplemented with flowthrough cells to limit cell loss due to staining. 
Antibody staining, live/dead discrimination and DNA staining were 
performed as described (55) before acquisition on the CyTOF. 
 
3.24  STELA assay and data analysis 
T cells (6,000 cells/subset) were FACS-sorted in PBS–/–, washed twice in 
PBS–/– and frozen at -80°C. Then, DNA was extracted using a QIAamp 
DNA Micro Kit (Qiagen). Single telomere length analysis was carried out at 
the XpYp telomere as described previously128. Briefly, genomic DNA was 
eluted in 35 µL Tris (10 mM) to which 0.75 µL Telorette-2 linker (10 µM) 
was added. Multiple PCRs were then performed for each test DNA. Each 
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reaction was set up in a final volume of 10 µL containing 1 µL of DNA and 
0.5 µM of the telomere-adjacent and Teltail primers in 75 mM Tris-HCl pH 
8.8, 20 mM (NH4)2SO4, 0.01% Tween-20, and 1.5 mM MgCl2, with 0.5 U 
of a 10:1 mixture of Taq (Thermo Fisher Scientific) and Pwo polymerase 
(Roche Molecular Biochemicals). The reactions were processed in a 
Tetrad2 Thermal Cycler (Bio-Rad). DNA fragments were resolved via 
0.5% Tris-acetate-EDTA agarose gel electrophoresis and identified via 
Southern hybridization with a random-primed anti-32P-labeled 
(PerkinElmer) TTAGGG repeat probe, together with probes specific for 
molecular weight markers at 1 kb (Stratagene) and 2.5 kb (Bio-Rad). 
Hybridized fragments were detected using a Typhoon FLA 9500 
Phosphorimager (GE Healthcare). The molecular weights of the DNA 
fragments were calculated using a Phoretix 1D Quantifier (Nonlinear 
Dynamics). 
 
3.25  Library preparation and Assay for Transposase-
Accessible Chromatin using sequencing (ATAC-seq) 
Cells were FACS-sorted in 500 μL of R10. Freshly sorted 50,000 cells 
from each subset were washed in PBS-/- and resuspended in 50 μL of 
Lysis Buffer (10mM Tris-HCl pH 7.4, 10mM MgCl2, 0.1% Igepal CA-630). 
Nuclei were pelleted by centrifugation for 10 min at 500g, 4°C, and 
resuspended in 50 μL of reaction buffer containing 1 μl of Tn5 transposase 
(made in house), 10 μL of 5x transposase buffer (50mM Tris-HCl, pH 8.4 
and 25mM MgCl2), and 39 μL of milliQ water. The reaction was incubated 
at 37°C for 30 min with mixing at 300 RPM, followed by the addition of 10 
μL of clean-up buffer (900mM NaCl, 30mM EDTA), 5 μL of 20% SDS, 0.7 
μL of milliQ water and 4.3 μL of Proteinase K (18.6 μg/μL) (Thermo Fisher 
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Scientific) and incubation for 30 min at 40°C. Tagmented DNA was 
isolated using SPRI beads (2x) and amplified by PCR. Fragments smaller 
than 600 bp were isolated by negative size selection (using 0.65x SPRI 
beads) and then purified with 1.8x SPRI beads. Libraries were qualitatively 
assessed by using TapeStation 4200 and quantified by Qubit Fluorimeter. 
Libraries were then multiplexed in an equimolar pool and sequenced on a 
NextSeq-500/550 Illumina Platform by generating between 20 and 50 
million 75bp-SE reads per sample, depending on the experiment. 
 
3.26  ATAC-sequencing analysis 
Read quality was assessed with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and low-quality 
bases and adaptors were trimmed by Cutadapt. Samples were aligned to 
GRCh38 reference genome with BWA mem with the default condition 
(v0.7.17)129. Mitochondrial reads were removed using SAMtools (v1.9) 
while PCR duplicated were filtered using MarkDuplicates function from 
Picard tool (v2.19) (http://broadinstitute.github.io/picard/). Open chromatin 
was detected with MACS2 (v2.1.2)130 with a FDR lower than 0.01. The 
number of reads in each peak was determined with featureCounts, 
differentially accessible peaks were identified after DESeq2 (v1.20) 
normalization using a FDR cut-off lower than 0.05. Peaks were annotated 
with HOMER annotatePeaks.pl and scanned for de novo and known 





3.27  Statistical analysis 
 Statistical analyses were performed using GraphPad Prism version 7 or R 
software version 3.4.3. P values were considered statistically significant 
when <0.05, unless specified otherwise. Statistical tests used in specific 




Chemicals, Peptides, and Recombinant Proteins
Recombinant human IL-2 Peprotech Cat # 200-02-A
Recombinant human IL-7 Peprotech Cat # 200-07-10UG
Recombinant human IL-12 Peprotech Cat # 200-12-10UG
Recombinant human IL-15 Peprotech Cat # 200-15B
Phorbol 12-Myristate 13-Acetate Sigma-Aldrich Cat # P8139-1MG
Ionomycin Calcium Salt Sigma-Aldrich Cat # I0634
Foxp3/Transcription Factor Staining Buffer Set eBioscience Cat # 00-5523-00
CellTrace CFSE Cell Proliferation Kit ThermoFisher Cat # C34554
Zombie Aqua Fixable Viability kit Biolegend Cat # 423101
GolgiPlug Protein Transport Inhibitor BD Biosciences Cat # 555029
Proteinase K Merck Cat # 3115887001
Universal PCR Master Mix no Amperase UNG ThermoFisher Cat # 4324018
Streptavidin BV421 Biolegend Cat # 405225
Streptavidin PE Sigma Cat # E4011-ML
Streptavidin APC ThermoFisher Cat # S32362
Ficoll-Paque Plus GE Healthcare Cat # 17-1440-03
Critical Commercial Assays
MojoSort human CD8 naïve isolation kit Biolegend Cat # 480046
EasySep human CD8+ enrichment kit Stem Cell Tech. Cat # 19053
MojoSort mouse CD8 isolation kit Biolegend Cat # 480035
RNeasy Micro Kit Qiagen Cat # 74004
CD14 Microbeads, human Miltenyi Biotech Cat # 130-050-201
CD8 Microbeads, human Miltenyi Biotech Cat # 130-045-201
Experimental Models: Organisms/Strains
C57BL/6 Charles River
B6:D2-TCR LCMV (P14) SWIMM
Oligonucleotides
TREC-F: CACATCCCTTTCAACCATGCT Sigma 8021100303-000010
TREC-R: GCCAGCTGCAGGGTTTAGG Sigma 8021100303-000020
TREC-PROBE : [6FAM]ACACCTCTGGTTTTTGTAAAGGTGCCCACT[BHQ1]Sigma 8021100303-000030
FAS-F: GGCTCTGTGAGGGATATAAAGACA Sigma 8021100303-000040
FAS-R: CAAACCACCCGAGCAACTAATCT Sigma 8021100303-000050




pGem T easy plasmid Promega N/A
Software and Algorithms
FlowJo v9 FlowJo LLC https://www.flowjo.com/solutions/flowjo/downloads
SPICE v5.3 NIAID https://niaid.github.io/spice/
Pestle NIAID 
Prism v7 GraphPad https://www.graphpad.com/scientific-software/prism/
Other
Trucount Tubes BD Cat # 340334
MicroAmp Fast Optical 96-Well reaction Plate Applied BiosystemsCat # 43-469-06
Table 3: List of the reagents used in the study 
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4  Results 
4.1  Results part 1 
4.1.1  CXCR3 identifies subsets of TN cells in humans 
 
4.1.1.1 Phenotypical characterization of TNR3- and TNR3+ 
We aimed to analyze human TN cells according to stringent phenotypic 
characterization, i.e., defined as CD45RO- CCR7+ CD27+ CD95- in order 
to exclude any possible memory contaminations. We found that CXCR3, a 
C-X-C motif chemokine receptor involved in migration towards inflamed 
tissues, was not uniformly expressed by CD8+ TN cells. We were able to 
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clearly distinguish CXCR3- and CXCR3+ CD8+ TN cells (from here referred 
as TNR3- and TNR3+, respectively) (Fig 4A). This unprecedented 
heterogeneity within the TN compartment allowed us to perform an in 
depth characterization of these two newly discovered subsets, which 
constitute the CD8+ TN pool showed in Fig 1. We confirmed CXCR3 
expression on the surface of CD8+ TN cells with two different anti-CXCR3 
antibody clones, obtaining similar frequencies of positive cells (Fig 4B). 
There is evidence that chemokine receptor expression is affected by 
cycles of freezing-thawing132; thus we compared CXCR3 expression on 
freshly isolated PBMCs and on cryopreserved PBMCs from the same 
donors. Results in Fig 4C show a reduction in CXCR3 expression on 
thawed samples, therefore we performed most of our assays using freshly 
isolated PBMCs.  
We next aimed to confirm these differences in protein expression also at 
the mRNA level, and thus developed a FACS sorting panel in order to 
isolate TNR3- and TNR3+ for additional studies. We thus flow-sorted TNR3- 
and TNR3+ from healthy controls (HC) PBMCs and confirmed that CXCR3 
mRNA is detected in all donors in TNR3+ cells while was lower or 
undetected in TNR3- cells (Fig 5A).   
Figure 4: CXCR3 identifies two subsets of TN-phenotype cells in the human 
body. A) Representative flow cytometry analysis of CXCR3 expression by 
CD45RO–CCR7+CD27+CD95– TN-phenotype CD8+ and CD4+ T cells. Numbers 
indicate the percentage of positive cells identified by the gates. B) 
Representative flow cytometry analysis of CXCR3 expression on CD8+ TN cells 
as detected by two clones of fluorescently-conjugated antibodies. Similar data 
were obtained from 4 more individuals. C) Mean±SEM percent CXCR3 
expression by CD8+ TN cells identified in PBMCs that are fresh or after 
freezing/thawing in liquid nitrogen (n=5). *=P<0.05, paired t-test. 
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In order to define the relative abundance of TNR3- and TNR3+ amongst 
total CD8+ T lymphocytes, we performed phenotypic analysis of peripheral 
blood (PB) from HCs via FACS. Fig 5B shows that TNR3+ are ~3-fold more 
abundant compared to TNR3- under physiological conditions. We then 
investigated the immunophenotypes of TNR3- and TNR3+ subsets. To this 
aim, we took advantage of a publicly available data set from Wong et al., 
who analyzed the surface proteome of CD8+ T cells from several human 
tissues by CyTOF124. This included markers of differentiation, homing and 
activation/costimulation. As depicted in Fig 6A, both TNR3- and TNR3+ 
Figure 5: CXCR3 mRNA quantification of TN subsets and their relative 
abundance amongst total CD8+T cells. A) Mean±SEM expression of CXCR3 
relative to B2M mRNA in FACS-sorted TNR3– and TNR3+ cells (n=5). N.d.: not 
detected. Same color indicates same donor of provenience. B) Mean±SEM 
frequency of T cell subsets in the peripheral blood of healthy individuals (n=26). 
TSCM, Stem Cell Memory: CD45RO CCR7+CD27+CD95+; TCM, Central Memory: 
CD45RO+CCR7+; TEM, Effector Memory: CD45RO+CCR7–; TTE, Terminal 
Effectors: CD45RO–CCR7–. 
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displayed a TN differentiation profile, characterized by the simultaneous 
expression of CD45RA, CD27, CD62L and CD127 in concomitance with 
the absence of CD95 and CD57. Analysis of homing and 
activation/costimulation molecules also revealed a clear TN profile, with the 
lack of expression of tissue residency markers, integrins, chemokine 
receptors and activation markers (CD69, CD103, CD49a, CD49d, CCR5, 
Figure 6: Phenotypic analysis of human TN subsets. A) Heatmap of percent 
antigen expression by CD8+ T cell subsets identified in the peripheral blood. 
Memory subsets were defined as in Fig 5B. B) t-SNE map representation of 
surface immunophenotypes of circulating TNR3–, TNR3+ and TMEM cells (defined 
as CD45RO+) on top of total CD8+ T cells from the different tissues analyzed, as 




CCR6, CLA, CD38, HLA-DR, PD-1 and others) generally expressed by 
memory cells. Taken together, these observations revealed a shared 
phenotype between TNR3- and TNR3+ cells. In line with this observation, 
dimensionality reduction analysis performed with t-distributed stochastic 
neighbor embedding (tSNE) showed that TNR3- and TNR3+ have a similar 
profile, instead conventional CD45RO+ memory T cells mapped in a 
clearly distinct region (Fig 6B). 
 
4.1.1.2  Tissue homing and distribution of TNR3- and TNR3+ 
Under physiological conditions, human TN cells are preferentially present 
in blood and lymphoid tissues133. Consistently with this observation, 
analysis of tissues from the same dataset of Fig 6A revealed that TNR3- 
and TNR3+ are not present in gut, skin and lung, while are present in 
tonsils and, with at a lesser extent, in spleen and liver (Fig 7A). 
Furthermore, we also investigated by FACS the presence of TNR3- and 
TNR3+ in lymph-nodes (LN) obtained from patients with head and neck 
cancer and in paired PB samples, and found comparable frequencies (Fig 
7B). Surface markers analysis, performed as in Fig6A, displayed that 
TNR3- and TNR3+ in tonsil, spleen and liver possess an identical phenotype 
compared to PB, and that both subsets lacked the expression of tissue-
residency markers CD69 and CD103. Moreover, t-SNE analysis 
performed on the same tissues displayed a similar spatial distribution of 
subsets compared to the same analysis on PB (Fig 7D). These data 
suggest that CXCR3 does not affect CD8+ TN cell trafficking.  
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4.1.1.3  Abundance of TNR3- and TNR3+ during aging 
Aging is characterized by a decline in the functionality of the immune 
system 134, in particular T cell responsiveness and pool composition are 
affected by advanced age135. Since TN cell frequency is known to 
decrease with age, we investigated the balance of TNR3- and TNR3+ in the 
PB of a cohort of 1938 individuals with an age range from 19 to 105 years 
from a previously reported cohort108,109. Fig 8 displays that both TNR3- and 
TNR3+ decreased with age, but with different slope (Fig 8A and 8B). 
Frequency of TNR3+, in fact, resulted slightly increased with aging, thus 
Figure 7: Tissue distribution of TN subsets. A) Mean±SEM frequency of 
TNR3– and TNR3+ cells among total CD8+ T cells isolated from human tonsils 
(n=5), spleen (n=3), liver (n=3), gut (n=6), skin (n=5), lung (n=4), as determined 
by CyTOF. *=P<0.05, Student’s t-test. B) Percent ratio of TNR3+/TNR3− cells in 
paired LN and PB samples. Data are shown as mean ± SEM. C) Percent 
antigen expression by CD8+ T cell subsets identified in the indicated tissues. 
Memory subsets were defined as in Figure 5B. D) tSNE map representation of 
surface immunophenotypes of TNR3– and TNR3+ cells along with TMEM cells 
(defined as CD45RO+) on top of total CD8+ T cells from the indicated tissues. 
All markers listed in B except for CXCR3 were used for the tSNE map. 
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4.1.2  True naivety of TNR3+ cells 
 
4.1.2.1  Replicative history of TNR3-  and TNR3+ 
Previous work from Song and colleagues focused on a small subset of 
CXCR3+ cells within the CD4+ TN compartment136 (Fig 4A). Interestingly, 
these cells display functional responses and gene expression profile 
typical of memory cells, and resulted precursors of Th1 cells. Also recently 
work from Murata et al. identified a CXCR3+ CD8+ TN-like population as 
young memory T cells137. Thus we performed a plethora of assays with the 
aim to investigate whether TNR3+ cells might represent a subset of early 
differentiated CD8+ memory T cells or a population of true naïve cells, and 
to deeply characterize the naïve vs memory features of TNR3- and TNR3+. 
First, we move to analyze the replicative history of TNR3- and TNR3+, by 
measuring T Cell Receptor Excision Circles content (TRECs). TRECs are 
Figure 8: Abundance of TNR3- and TNR3+ during aging. A) Frequency of 
TNR3–cells on total CD8+ in 1,938 individuals with different age (19-105 y.). 
Red line indicates linear regression. Effect size and p-value are indicated for 
each correlation. B) Frequency of TNR3+ on total CD8+ in the same cohort in 
A. C) Frequency of TNR3+ on total TN in the same cohort in A and B. 
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possibility to effectively quantify cell divisions underwent by a specific cell 
population. Ex vivo assay for quantification of TRECs copies measured by 
quantitative real-time PCR138 revealed that TRECs were ~ 2-fold more 
abundant in TNR3- compared to TNR3+, ~ 4-fold more abundant in TNR3- 
compared to TSCM and ~ 25-fold more abundant in TNR3- compared to 
conventional CD45RO+ memory T cells (Fig 9). According to data, TNR3+ 
underwent on average 1 additional cycle of cell division in vivo, at the 
population level, compared to TNR3-. This mild difference suggests a 




Figure 9: Replicative history of TNR3-  and TNR3+. Mean±SEM copies of 
TREC as relative to TNR3– in FACS-purified T cell subsets isolated from the 
peripheral blood (n=10 for all subsets except for TSCM, n=4). Numbers indicate 
the fold change of copies as relative to TNR3–. *=P<0.05, **=P<0.01, 
****=P<0.0001, non-parametric ANOVA with Dunn’s posttest. 
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4.1.2.2  Antigen specific clonal expansion of TNR3- and TNR3+ 
Naïve T cell compartment is characterized by the absence of clonally 
expanded cells, specific for exogenous antigens, but in some cases are 
present large number of precursors specific for self-antigens139. In 
particular, precursor frequency of Melan-A/MART-1-specifc T cells is at 
least 100-fold larger than that of TN cells with other specificities140. The 
mechanism at the basis of this difference is poorly understood, but is 
known to originate in the thymus. Naivety of Melan-A/MART-1-specifc T 
cells, as revealed by TREC dilution and telomere length, is maintained in 
the periphery, and is thus conceivable with the concept of antigen 
ignorance140.    
According to these previous observations, TNR3- and TNR3+ does not 
display cells specific for immunodominant epitopes derived from CMV and 
Flu, while cells specific for the same epitopes are present in TSCM and in 
TMEM populations. Furthermore, cells specific for immunodominant epitope 
derived from Melan-A/MART-1 were present in both TNR3- and TNR3+ (Fig 
10A and B). Recently, work from Pulko and colleagues identified in the 
CD8+ T cell compartment a rare population of memory cell with a naïve 
phenotype (TMNP), which are characterized by the expression of CD49d 
and high levels of CXCR3, and by the capability to produce IFN-γ after 
stimulation with mitogens (PMA and Ionomycin)141. Furthermore, TMNP 
revealed to include cells specific for epitopes derived from persistent 
viruses, like CMV and EBV; on the contrary, they do not display cells 
specific for epitopes derived from acute viruses, like Flu. In contrast with 
these data, we observed Flu-specific cells CD8+ T cells, but not CMV-
specific ones within the TMNP compartment, which is included in the TNR3+ 
cell population (~ 0,5% of the TNR3+ subset) (Fig 10A and B).  
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4.1.2.3  Ag-specific precursors compartmentalization in CD8+ TN 
subsets 
Data shown in Fig 10A and B on MART-1 Ag-specific cells suggested that 
Ag-specific precursors are not preferentially compartmentalized in one 
determined subset of CD8+ TN cells. To confirm this hypothesis, we 
Figure 10: Antigen specific clonal expansion of TNR3- and TNR3+. A) 
Representative flow cytometry analysis of CMV, Flu and MART-1 HLA-A*02 
tetramer binding in relation to CXCR3 expression in peripheral blood T cell 
subsets. Top row shows CD45RO–CCR7+CD27+CD95– TN-phenotype cells, further 
gated as TNR3–, TNR3+ and TMNP cells.  B) Mean±SEM percent of the data as in C 
(CMV, n=6; Flu, n=7; MART-1, n=8). N.d.= not detected due to low numbers. 
*=P<0.05 and **=P<0.01, non-parametric ANOVA with Dunn’s posttest. 
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investigated the presence of cells specific for exogenous Ags within TNR3- 
and TNR3+. We screened amplified libraries of TNR3- , TNR3+ and 
CD45RO+ TMEM with peptide-pulsed autologous APCs112. CD8+ T cells 
specific for previously unencountered antigens, like HIV-1 and Zika virus, 









compartments and with a similar extent. Only one donor constituted an 
exception, displaying high frequencies of HIV-1-specific only within TNR3- 
cell pool, probably indicating TCR cross-reactivity. Interestingly, Ag-
specific cells for the more common viruses investigated in previous 
experiments (CMV, EBV and Flu) confirmed a similar trend even with this 
different experimental setting. Furthermore, CD8+ TMEM cells did not 
display cells specific for previously unencountered antigens, while on the 
other hand, Ag-specific cells for more prevalent viruses resulted abundant 
in TMEM compartment (Fig 11).  
 
Figure 11: Ag-specific precursors compartmentalization in CD8+ TN 
subsets. Frequency of antigen-specific CD8+ T cell precursors among TNR3–, 
TNR3+ and TMEM cells. Bars indicate the median of the distribution while each dot 




4.1.3  TNR3+ are biased towards effector differentiation 
 
4.1.3.1  TNR3+ cells display an effector-prone gene expression profile  
After achieving information regarding phenotypical and functional 
characterization of TN cell subsets we then move to assess relationship 
between TNR3- and TNR3+ and TMEM at the gene expression level. In order 
to do this, we FACS-sorted matched TNR3- and TNR3+ and TMEM from 4 
HCs and subsequently performed RNA Microarray assay. To obtain 
immediate hints regarding similarity of subsets investigated we performed 
a principal component analysis (Fig 12A), which revealed that TNR3- and 
TNR3+ are predominantly distinct from CD45RO+ TMEM cells. Furthermore, 
TNR3- and TNR3+ resulted spatially very close in the plot, thus displaying a 
high degree of similarity in terms of gene expression profile. Paired 
analysis of the samples identified 345 differentially expressed genes 
(DEGs) with p < 0.01 between TNR3- and TNR3+ cells. As shown in the 
heat map depicted in Fig 12B, effector/memory-related transcripts like 
ANXA1, EOMES and MYB, and the costimulatory receptor CD226, which 
encodes DNAX accessory molecule-1 (DNAM-1) resulted upregulated in 
TNR3+ cells. Applying a less stringent cut-off (p < 0.05) was possible to 
identify 2567 DEGs, which included among others BHLHE40, a 
transcription factor related to effector differentiation, and NT5E, which 
encodes CD73, a surface enzyme involved in adenosine generation, both 
preferentially expressed by TNR3+ cells. Interestingly, TNR3- cells 
displayed overexpression of transcription factors associated with the 




We next performed gene set enrichment assay (GSEA) in order to capture 
global transcriptional trends at the level of gene signatures rather than at 
the level of single genes. This analysis displayed that gene sets involved 
in mitochondrial activity like respiratory electron transport chain 
(REACTOME Database) and pathways of genes associated with effector 
and memory differentiation (Immunological Signature Database) were 
significantly enriched in TNR3+ versus TNR3- cells (FDR < 0.001; Fig 12C). 
Overall, these data suggested that TNR3+ cells are better poised to 
differentiate and acquire effector functionality compared with TNR3- cells.  
 
Figure 12: TNR3+ cells display an effector-prone gene expression profile. A) 
Principal component analysis based on the expression levels of genes with a 
coefficient of variation larger than the 90th percentile of the coefficients of variation 
in the entire dataset as obtained from microarray analysis (n=4/subset). B) 
Heatmap of DEGs between TNR3– and TNR3+ cells (n=4; P<0.01). The most 
relevant genes involved in immune functions are listed. C) Normalized enrichment 
score (NES) and false discovery rate (FDR) of the indicated gene signatures 
enriched in TNR3+ vs. TNR3- cells, as obtained by GSEA. 
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4.1.3.2  TNR3+ cells possess increased cytokine production in vitro 
We then moved to assess whether these observations regarding gene 
expression profile reflect on increased effector functions capability in 
TNR3+ cells compared to TNR3- cells. In order to do this, we FACS-sorted 
TNR3- and TNR3+ from HCs alongside with TMEM, stimulated directly ex 
vivo with PMA and ionomycin for 6 hours and measured cytokine 
production by FACS. As depicted in Fig 13A, TNR3+ cells resulted capable 
to produce higher amount of TNF-a and IL-2 compared to the TNR3- 
counterpart. Increased IL-2 production might be related to the lower 
expression of IKZF1 in TNR3+, which is a negative regulator of IL-2 
Figure 13: TNR3+ cells possess increased cytokine production in vitro. 
A) A) Mean±SEM percent of FACS-purified subsets producing IL-2, TNF-a 
and IFN-γ following PMA/ionomycin stimulation for 6 hours (n=6 for TNR3– vs. 
TNR3+, n=2 for TMEM). B) Representative CFSE dilution at day 10 of T cell 
subsets following HCMV lysate and CMV peptide pool stimulation. C) 
Mean±SEM percent of CMV-specific CD8+ T cells diluting CFSE, obtained as 
in B (n=5). *=P<0.05, non-parametric ANOVA (Friedman test). 
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production in CD8+ T cells142. Furthermore, according to their naïve status, 
no IFN-γ production was detected in both TNR3- and TNR3+ cells, thus 
providing additional confirmation of the naivety of both subsets. We then 
investigated effector functions capability of TN subsets at the Ag-specific 
level. To do this, we FACS-sorted TNR3-, TNR3+ and TMEM from CMV-
seronegative donors and cultured for 10 days with autologous monocytes 
pulsed with human CMV lysate and a CMV peptide pool. CMV-specific 
response was detected in both TNR3- and TNR3+ but not in the TMEM pool, 
as assessed by CFSE dilution (Fig 13B and C). Moreover, on day 10, cells 
were stimulated with PMA and ionomycin to measure cytokine production, 
and an increased expression of IFN-γ, perforin and TNF-a was observed 
in Ag-specific CFSE-diluted TNR3+ cells in comparison with correspondent 
TNR3- (Fig 14A and B).   
Figure 14: Ag-specific TNR3+ cells possess increased cytokine 
production in vitro. A) Representative flow cytometry analysis of effector 
molecules production following PMA/ionomycin stimulation by CFSE- diluted, 
CMV-specific TNR3– and TNR3+ CD8+ T cells, obtained as in 10B. Numbers 
indicate the percentage of cells identified by the gates. B) Mean summary of 
the data as in A. Each dot represents a different donor. * P<0.05 and *** 
P<0.001, paired t-test. 
 63 
 
 4.1.3.3  TNR3+ cells possess increased cytokine production in vivo 
To extend our in vitro observations on human CMV-specific precursors to 
a physiological setting in vivo, we investigated whether phenotypically 
similar TN cell subsets could be identified in the mouse. Indeed, we could 
observe that a subpopulation of murine CD44loCD62Lhi CD8+ TN cells 
expresses CXCR3, although with a different frequency compared to 
human TN cells (~10% vs. ~60%; Fig 15A and Fig 4A, respectively). Next, 
we FACS-purified murine TNR3–  
 
Figure 15: Ag-specific TNR3+ cells possess increased cytokine production 
in vivo. A) Representative gating strategy for the identification of murine TNR3– 
and TNR3+ cells in LCMV P14 TCR transgenic mice. B) Schematic 
representation of the murine adoptive transfer experiment. C) Mean±SEM 
frequencies (%) of spleen KLRG1+ IL-7Ra– SLECs among adoptively 
transferred P14-specific TNR3– and TNR3+ CD8+ T cells (left panel) and CXCR3 
and KLRG1 MFI in SLECs (center and right panel, respectively) at different 
days post LCMV infection (n=5 mice/group). *=P<0.05 and **=P<0.01, unpaired 
parametric t-test. 
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and TNR3+ cells from unimmunized, LCMV P14 TCR-transgenic mice, and 
adoptively-transferred them into wild type hosts that were subsequently 
infected with the LCMV Armstrong strain (causing an acute infection; Fig 
15B). By analyzing the progeny of these cells, distinguished from the 
endogenous response by specific congenic markers, we found that murine 
TNR3+ cells generated a higher frequency of KLRG1+ IL-7Ra– SLECs at 
day 7 and day 14 after infection. Moreover, SLECs deriving from TNR3+ 
cells featured higher levels of CXCR3 and KLRG1 protein expression at 
day 7 post infection than their TNR3– counterparts (Fig 15C). We conclude 
that also murine TNR3+ cells are biased towards effector differentiation 
following antigen-specific stimulation in vivo.  
 
4.1.4  TNR3- and TNR3+ cells express qualitatively distinct TCRs 
We then decided to investigate whether this bias in terms of effector 
function and differentiation of TNR3+ compared to TNR3- could be related 
to different intrinsic features of TCR reactivity. Tonic TCR signaling driven 
by self-p:MHC-I complexes is fundamental for TN homeostasis and 
maintenance (see Introduction). In mice, increased TCR reactivity against 
self-Ags correlates with the expression of CD5 and indicates the ability of 
TN to respond to foreign antigens70–72. Thus, we initially investigated levels 
of expression of CD5 on the surface of TNR3- and TNR3+. As depicted in 
Fig 16A, we found that human TN subsets uniformly express CD5 on their 
surfaces, suggesting that CD5 may not identify differential T cell reactivity 
of human TN cells. Alternatively, physicochemical properties of TRB CDR3 
sequences, as determined by TCR sequencing, can indirectly inform on 
the strength of interaction between the TCR and p:MHC-I 
complexes73,116,143–147. We thus performed TCR deep sequencing on 
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FACS-sorted TNR3-, TNR3+ and TMEM cells in order to investigate their 
respective TRB repertoires. First, we performed an analysis of TRBV-
TRBJ  
 
usage on individual HCs, and found that TNR3- and TNR3+ display highly 
similar patterns according to Jenson-Shannon divergence analysis (Fig 
16B), indicating that they are highly related. In contrast, TMEM cells 
revealed distinct patterns of TRBV-TRBJ. According with their naïve 
Figure 16 : TNR3- and TNR3+ cells express qualitatively distinct TCRs.  
A) Representative flow cytometric analysis of surface CD5 on human TNR3–, 
TNR3+ and TMEM cells. Similar data were obtained from 3 more individuals. B) 
Cluster analysis of TRBV-TRBJ usage, as obtained by TCRseq, in sorted 
TNR3– and TNR3+ cells (both n=5). Data are from a subset of individuals from 
a single sequencing experiment where also TMEM cells (n=3) were analyzed. 
C) Normalized Shannon-Wiener diversity index and D) Chao1 diversity index 
of TCRseq data (calculated for 5,000 unique UMI-labeled TRB CDR3 
molecules; n=11 from two independent experiments). ***= P<0.001, Tukey’s 
range test. E) Averaged (weighted per clonal size) Kidera Factor 4 (KF4), MJ 
energy, Strength and Volume VDJtools physico-chemical characteristics of 5 
amino acids in the middle of CDR3 sequences in TNR3– and TNR3+ cells TRB 




status, TNR3– and TNR3+ showed high and very similar diversity of TRB 
sequences, as displayed in Fig 16C and D by normalized Shannon-Wiener 
and Chao1 metrics calculated for 5,000 randomly chosen TCR beta cDNA 
molecules. As expected on the basis of their clonal expansion, diversity 
was much lower in TMEM cells. We then moved to investigate the averaged 
physicochemical properties of the central region of each TRB CDR3 
sequence, composed by 5 aa residues, which is mainly responsible for the 
contact with p:MHC-I complexes. As shown in Fig 16E, analysis by 
VDJtools115 displayed that, at the population level, TNR3+ possess 
augmented hydrophobicity, as assessed by lower Kidera factor 4 (KF4), 
lower energy117,144 and higher strength and volume parameters compared 
to the TNR3- cell pool. Taken together, these parameters suggest that 
TNR3+ are characterized by TCRs with augmented intrinsic affinities for 
cognate Ags (being that either self or non-self) compared to TNR3– cells. 
 
4.1.5  TNR3+ cells are transcriptionally equivalent in human and mice 
To corroborate findings of possible increased reactivity of TNR3+ vs. TNR3- 
cells with a defined model, we turned to analyze the murine polyclonal 
CD44lo CD62Lhi CD8+ TN compartment. Murine TNR3+ T cells are 














shown to respond more vigorously to foreign antigens compared to CD5lo 
and CD5hi TN cells. In order to obtain an all-encompassing characterization 
of TN heterogeneity in murine compartment, we FACS-sorted 
CD5loCXCR3– (referred to as CD5lo), CD5hiCXCR3– (CD5hi) and 
CD5hiCXCR3+ (TNR3+) from the CD44loCD62Lhi TN cell pool (Fig 17C) 
along with CD44hi conventional memory T cells, and defined their 
transcriptional profile using RNA sequencing (RNAseq). As depicted in Fig 
18A, according to biological coefficient of variation, all murine CD8+ TN 
subsets resulted clearly separated from conventional TMEM cells. 
Nevertheless, gene expression analysis identified 636 DEGs (FDR < 
Figure 17 : Characterization of murine TN subsets. A) Representative flow 
cytometry analysis of CXCR3 and CD5 expression by murine CD44loCD62Lhi 
CD8+ TN cells. B) Mean fluorescence intensity (MFI) of CD5, as determined by 
flow cytometry, by murine TNR3– and TNR3+ cells (gated as 
CD44loCD62LhiCXCR3– and CD44loCD62LhiCXCR3+, respectively; n=5; 
P<0.0001, paired t-test). C) Post-sort purity, as obtained by FACS, of CD8+ TN 
subsets identified by differential CD5 and CXCR3 expression. 
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0.001) among the murine TN subsets.  Besides Cxcr3 and Cd5, murine 
TNR3+ had increased expression of effector T cell-associated genes 
including Tbx21, Ccl5, Irf8, Hopx, Junb, Fos and Jun compared to both 
CD5lo and CD5hi TN cells, among others (Fig 18B) while, with less stringent 
criteria (FDR<0.05), decreased expression of naïve T cell-associated 
genes, including Lef1 and Ccr7. Importantly, genes previously found 
differentially expressed between human TN subsets such as Ccr9, Eomes, 
Nt5e and Myb or Sox4 and Ikzf1 were also found differentially expressed 
in murine TN subsets. According to these data, gene signatures composed 
by the genes upregulated in murine TNR3+ vs. CD5hi and in murine TNR3+ 
vs. CD5lo, containing 37 and 221 genes, respectively (FDR < 0.001), 
resulted preferentially enriched by GSEA in human TNR3+ compared to 
TNR3– cells. These data indicate that murine TNR3+ with enhanced effector 
T cell differentiation potential are transcriptionally equivalent to human 
TNR3+ counterpart (Fig 18C). 
  
Figure 18 : Gene expression profile of murine TN subsets. A) Biological 
coefficient of variation (BCV) plot of RNAseq profiles of murine CD8+ TN subsets 
isolated as in 15C (n=5/subset). Bulk memory CD8+ T cells are CD44hi (n=3). B) 
Heatmap of differentially expressed genes (FDR<0.0001) among subsets sorted 
as in 15C. The most relevant genes involved in immune functions are listed. C) 
GSEA plots of murine TNR3+ vs. CD5hi (top) and vs. CD5lo (bottom) gene sets 
significantly enriched in human TNR3+ cells. NES: normalized enrichment score. 
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4.2  Results part 2 
 
4.2.1  Heterogeneity of the human memory CD8+ T cell pool as 
revealed by high dimensional single cell analysis 
 
4.2.1.1  Single-cell RNA sequencing of the human CD8+ T cell 
memory pool 
 We initially used single-cell RNA sequencing (scRNAseq; 10X Genomics 
platform) to characterize the full spectrum of human CD8+ memory T cells 
in peripheral blood (PB). A total of 31,640 cells were isolated for this 
purpose via fluorescence-activated cell sorting (FACS) based on the 
expression of CD95 which identifies a vast majority of all memory T cells 
in humans25 (Fig 19A). Bioinformatic analysis of gene expression mapped 
in two dimensions via Uniform Manifold Approximation and Projection 
(UMAP)148 (Fig 19B), a dimensionality reduction tool, which also takes in 
Figure 19 : Clusters identification in human memory T cell pool. A) 
Schematic representation of the sorting strategy of total memory CD95+ CD8+ T 
cells for scRNAseq processing. B) CD8+ memory T cells were sorted from four 
healthy donors’ peripheral blood and processed for 10X Genomics scRNAseq. 
The UMAP plot shows the distribution of ~32,000 cells in 13 clusters. Selected 
genes shown are differentially expressed compared to all the other clusters. C) 
Histogram plot showing the frequency of each cluster derived from the 
scRNAseq. Dashed line sets a threshold at 1%. 
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consideration the relationship between cluster’s similarity and spatial 
distance in the plot, identified 14 distinct clusters (denoted individually as 
C). As depicted in Fig 19B, were uniformly distant from the other cell 
populations and expressed high levels of KLRB1, which encodes CD161, 
and IL7R, which encodes the interleukin (IL)-7 receptor (IL-7R), also 
known as CD127. These clusters were therefore derived from mucosal 
associated invariant T (MAIT) cells149. An intermediate cluster, C9, which 
comprised less than 2% of all cells (Fig 19B) overexpressed TRDC and 
TRGC1, which encode the constant regions of the T cell receptor (TCR) δ 
and γ chains, respectively, suggesting the expression of gd rather than ab 
TCRs. In order to get information regarding the relative abundance of sub-
populations, we plotted frequencies of clusters on bar graph (Fig 19C). We 
established a cut-off threshold of 1%, in order to exclude those really small 
populations which might not have a significant biological function.  
 
4.2.1.2  Transcriptional heterogeneity in the CD8+ memory T cell 
compartment consists of 5 distinct clusters 
scRNAseq further identified seven different clusters related to 
conventional memory T cells (Fig 19B), the most abundant of which were 
C0, C2, C3, C6, and C10 (Fig 17C). C2, C6, and C10 expressed genes 
associated with long-lived memory T cells, including LEF1, SELL, which 
encodes L-selectin (CD62L), CCR7, and FOXP1 (Fig 19B and 20A). 
Among these clusters, C10 lacked CCR7 and expressed relatively high 
levels of Fc receptor-like protein 3 (FCRL3). Overall, these data suggest 
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transcriptional heterogeneity in the early differentiated memory T cell pool 
















In contrast, the highly abundant C0 overexpressed multiple effector 
transcripts, including GZMK and GZMM, which encode serine proteases 
termed granzymes, IFNG, which encodes interferon (IFN)-γ, the 
chemokine (C-C motif) ligands CCL4 and CCL5, and genes encoding 
Figure 20 : Features of identified memory T cell clusters. A) and B) 
Balloon plot showing the average expression of selected genes and the 
frequency of expression within each cluster from Fig 17B in a comparison 
between (A) all the clusters or (B) C6 versus C2. C) Anchor gene analysis of 
the dataset in Fig 17B CCR7, GZMK, GZMB, LEF1, ZEB2 and FOXP1 were 
selected as anchor genes to obtain a list of correlated genes on the basis of 
Pearson correlation coefficient. This generated six gene correlated modules. 
The three graphs show the distribution of C0, C2, C3, C6 and C10 on the 
axis according to their correlation scores. 
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human leukocyte antigen (HLA) class II molecules, consistent with the 
identification of effector memory T (TEM) cells (Fig 19B and 20A). 
C3 displayed a gene expression profile reminiscent of terminal effector T 
(TTE) cells, featuring high levels of GZMB, GNLY, NKG7, ZEB2, and 
GZMA (Fig 19B and 20A). A lack of signature transcripts precluded the 
identification of C8 based on current knowledge of the T cell differentiation 
pathway. C2, C6 and the less abundant C10 express genes associated 
with long-lived memory T cells, but with some peculiar differences. Both 
C2 and C6 are characterized by the expression of CCR7, SELL, LEF1 and 
TCF7 (which encodes for TCF1), while CCR7 expression was absent in 
C10, which instead  display increased expression of FCRL3, which in 
CD4+ T cells identifies a population of memory Tregs150. Taken together 
these preliminary observations on scRNAseq data, highlighted 
transcriptional heterogeneity within the CD8+ early memory pool.  
To explore the heterogeneity of the long-lived memory T cell pool, we 
focused on C2 and C6, because C10 comprised only ~1% of all sorted 
cells (Fig 19C). We identified 160 differentially expressed genes (DEGs) 
between C2 and C6. C2 expressed higher levels of effector molecules, 
including CCL5, GZMK, GNLY, GZMA, JUN, GZMM, HOPX, IKZF3, 
RUNX3, and PRF1, which encodes perforin, whereas C6 expressed 
higher levels of IL6R, LTB, LEF1, NOSIP, GATA3, and SELL (Fig 20B). 
We then used anchor genes selected from the most prominent DEGs to 
compute transcriptional modules associated with memory differentiation 
(correlated with CCR7 and LEF1), quiescence (correlated with FOXP1), or 
cytotoxicity and terminal effector differentiation (correlated with 
GZMK/GZMB and ZEB2, respectively) among the five conventional 
memory T cell clusters (C0, C2, C3, C6, and C10). Using this approach, 
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we found that C2 and C10 were similar, exhibiting intermediate memory 
and effector scores, whereas C6 was skewed toward a high memory score 
and C0 and C3 were skewed toward high effector scores (Fig 20C). 
scRNAseq analysis therefore identified four major subsets of conventional 
memory CD8+ T cells, namely early memory CCR7+ GZMK− (C6) or 
CCR7+ GZMK+ (C2), TEM-like CCR7− GZMKhigh (C0), and TTE-like GZMB+ 
(C3). 
 
4.2.1.3  Flow Cytometry characterization of memory T cell 
heterogeneity 
To confirm scRNAseq data at the protein level, we designed a high-
dimensional flow cytometry panel based on the cluster signature markers 
CCR7, LEF1, CD161, GZMB, and GZMK. This panel was also equipped to 
detect memory and effector differentiation markers (CD27, CD28, 
CD45RO, CD127, and T-bet), activation markers (CD38 and HLA-DR), 
inhibitory receptors [PD-1 and T cell immunoreceptor with Ig and ITIM 
domains (TIGIT)], and markers of tissue residency (CD69 and CD103). In 
line with the scRNAseq data, UMAP analysis of expressed proteins 
revealed that CD161bright MAIT cells were largely distinct from other CD95+ 
memory T cells (Fig. 21A). The CCR7+ GMZK− subset expressed relatively 
high levels of the memory markers LEF1, CD27, CD28, and CD127 and 
lacked effector molecules, activation markers, and inhibitory receptors, 
whereas the CCR7+ GMZK+ subset expressed intermediate levels of LEF1 
alongside PD-1 and TIGIT, which were not detected in the scRNAseq 
analysis, together with relatively high levels of CD27, CD28, and CD127 
(Fig. 21A). These subsets displayed variable expression of CD45RO (Fig. 
21A). Among the effector subsets defined at the transcriptional level, 
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CCR7− GZMKhigh cells expressed cytolytic and effector molecules 
alongside relatively high levels of CD69, were LEF1low, and lacked CD127 
and the residency marker CD103, whereas GZMB+ cells also expressed 
granulysin (GNLY) and relatively high levels of T-bet (Fig. 21A). As 
expected, CD69+ CD103+ cells were only detected in tissues (Fig. 21A). A 
survey of different tissue sites revealed that CCR7+ GZMK− PD-1− TIGIT− 
and CCR7+ GZMK+ PD-1+ TIGIT+ cells were relatively abundant in PB, 
lymph nodes (LNs), and bone marrow (BM), whereas CCR7− GZMKhigh 
cells were ubiquitous, and GZMB+ cells predominated in PB and lung 







4.2.2  Conventional TSCM and TCM constitute the same pool of memory 
cells following removal of GZMK+ cells with exhaustion traits 
 
4.2.2.1  Exhausted-like CD8+ memory T cell progenitors express 
GZMK, PD-1 and TIGIT 
Heterogeneity in the long-lived memory T cell pool became apparent with 
the identification of TSCM cells25. These cells exhibit a CCR7+ CD45RO− 
CD95+ phenotype, in contrast to TCM cells, which exhibit a CCR7+ 
CD45RO+ CD95+ phenotype. However, our scRNAseq-guided flow 
cytometric analyses demonstrated that the CCR7+ GZMK− PD-1− TIGIT− 
and CCR7+ GZMK+ PD-1+ TIGIT+ subsets could not be distinguished via 
the expression of CD45RO (Fig 21A). To place these findings in context, 
we investigated the expression of PD-1 and TIGIT among classically 
defined TSCM and TCM cells. We found that 9.1 ± 1.3% of TSCM cells and 
22.1 ± 2.3% of TCM cells (mean ± SEM) expressed both PD-1 and TIGIT 
(Fig 22A and B). On the basis of these results, we hypothesized that 
differential inclusion of the transcriptionally distinct CCR7+ GZMK+ PD-1+ 
Figure 21 : Characterization of memory T cell clusters by flow cytometry. A) 
UMAP visualization of 20 parameters flow cytometry. The left graph displays 
UMAP clustering of the different concatenated(top) and individual (bottom) tissues. 
The top left graph displays an overlay with CCR7+GZMK-, CCR7+GZMK+, CCR7-
TEM, CD161+ MAIT and GZMB+ TTE. The right graphs show the relative expression 
of each marker by positive cells for a specific marker on the UMAP (e.g. CD45RO 
expression by CD45RO positive cells). B) Frequency of the CCR7+GZMK-, 
CCR7+GZMK+, CCR7-TEM, CD161+ MAIT and GZMB+ TTE subsets within the 
analyzed organs. Data are shown as Mean ± SEM. Statistics were calculated only 
for the GZMK- and GZMK+ populations. *P < 0.05, **P <0.01 (Unpaired t test and 
Mann-Whitney test). 
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TIGIT+ subset could explain some of the previously reported differences 
between TSCM and TCM cells. 
 
We confirmed by manual gating of the flow cytometry data that PD-1 and 
TIGIT were preferentially expressed by CCR7+ GZMK+ cells (not shown), 
thereby justifying the use of these surface markers to viably separate this 
subset of cells. We next analyzed the transcriptomes of TSCM and TCM cells 
after depletion of the CCR7+ PD-1+ TIGIT+ (GZMK+) population (hereafter 
termed progenitor exhausted-like, or TPEX). In line with our hypothesis, 
such depleted subsets of TSCM and TCM cells were very similar and could 
only be distinguished on the basis of eight DEGs (adjusted p-value < 0.01) 
(Fig 23A). One of these DEGs was HNRNPLL, which encodes 
heterogeneous nuclear ribonucleoprotein L-like, a master regulator of 
alternative splicing responsible for the expression of CD45RO151. In 
Figure 22 : Early differentiated memory pool displays a GZMK+ 
contamination. A) Gating strategy showing the contamination of PD-1+TIGIT+ 
cells within classically defined Naïve (CCR7+CD45RO-CD28+CD95-), TSCM 
(CCR7+CD45RO-CD28+CD95+) and TCM (CCR7+CD45RO+) CD8+ T cell 
subsets on total PBMCs of a representative donor. B) Frequency of PD-
1+TIGIT+ cells within the classically defined Naïve, TSCM and TCM subsets (n=7, 
total PBMCs). Data are shown as median. **P < 0.01 (RM one-way ANOVA). 
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contrast, CCR7+ PD-1+ TIGIT+ TPEX cells were largely distinct, featuring 
lower expression levels of SATB1, which encodes a negative regulator of 
PD-1 expression152, MYC, DPP4, which encodes CD26, IL6ST, LEF1, 
IL6R, and NT5E and higher expression levels of transcription factor (TF) 
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cell exhaustion, including MAF153, EOMES154 and TOX99–102,155 and other 
genes associated with effector differentiation and cytolytic activity, 
including ZEB2, GZMK, GZMA, TBX21, PRF1, IFNG, and NKG7 (Fig 
23B). Moreover, GSEA further revealed that TSTEM cells were 
characterized by transcripts associated with the naive state, quiescence, 
oxidative phosphorylation, the Wnt24 and Notch signaling pathways156 and 
proteasome activity157, whereas TPEX cells were characterized by 
transcripts associated with the TGF-β signaling pathway158, potassium 
regulation159 and other mechanistic correlates of exhaustion, including the 
PD-1high state. Transcripts associated with the cell cycle and the TCR and 
mTOR signaling pathways, collectively suggesting a predisposition to 
antigen-driven proliferation and effector differentiation, were also 
upregulated in TSTEM versus TPEX cells (Fig 23C). In line with the 
transcriptional data, CCR7+ PD-1+ TIGIT+ TPEX cells stimulated with anti-
CD3/CD28 and a combination of effector (IL-2 and IL-12) or homeostatic 
cytokines (IL-7 and IL-15) proliferated less vigorously than PD-1– TIGIT– 
TSCM and TCM cells under identical conditions (Fig 24A). However, all three 
subsets proliferated similarly and remained phenotypically stable in 
response to IL-15, suggesting equivalent self-renewal capabilities. 
Accordingly, TSCM and TCM cells were better defined by the CCR7+ PD-1− 
Figure 23 : TPEX are characterized by a dysfunctional-like gene 
expression profile. Bulk RNAseq of CD8+ memory subsets FACS-sorted 
from the peripheral blood of five HCs. Heat-map shows genes differentially 
expressed (Q value < 0.01).  B) Heatmap showing differentially expressed 
genes (Q value< 0.01) by the indicated CCR7+memory CD8+ T cell subsets. 
Genes relevant for memory, effector or exhaustion differentiation are 
indicated. C) Histogram plot showing the normalized enrichment score (NES) 
of selected pathways obtained from GSEA in TSTEM versus TPEX cells. 
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TIGIT− phenotype, hereafter termed stem-like T (TSTEM), whereas early 
differentiated memory cells with exhaustion traits were characterized by 
the CCR7+ PD-1+ TIGIT+ TPEX phenotype. (Fig 24B and C) 
 
Figure  24 :Proliferative capacity of memory T cell subsets. A) Proliferation 
index of FACS-sorted memory subsets, obtained from HCs, stimulated with 
aCD3/CD28 (beads to cell ratio = 1:2) for TCR stimulation together with IL-2/IL-
12 (10 ng/ml, n=11) or IL-7/IL-15 (10 ng/ml, n=5) for four days (n=10 and n=5, 
respectively. Proliferation index was calculated as Proliferation index = MFI non-
proliferating fraction / MFI proliferating fraction × % cells with diluted CFSE. Data 
are shown as median. *P < 0.05; **P < 0.01; ***P < 0.001 (Paired t test and 
Wilcoxon test). B) Proliferation index of FACS-sorted memory subsets, obtained 
from HCs, stimulated with IL-15 (25ng/ml) for 10 days. Data are shown as in 
median. N=6. C) Histogram plot showing frequencies of markers expressed by 
the cells in B. Data are shown as median. *P < 0.05; **P < 0.01; ***P < 0.001; 






4.2.2.2  TSTEM are functionally superior to TPEX cells 
Data obtained from transcriptional analysis suggest that TPEX might feature 
a functional impairment in terms of proliferation, immune activation and  
effector function capacity compared to TSTEM. Thus we investigated 







In response to TCR-dependent stimulation with Staphylococcal 
enterotoxin B (SEB), FACS-purified TSTEM cells upregulated CD25 and 
CD69 to a greater extent than TPEX cells (Fig 25A), and activated CD25+ 
CD69+ TSTEM cells expressed higher levels of T-bet than activated CD25+ 
CD69+ TPEX cells (Fig 25B). Likewise, TSTEM cells produced cytokines at 
higher levels on a per cell basis (IFN-g, IL-2, and TNF) than TPEX cells in 
response to stimulation with anti-CD3/CD28 (Fig 25C, left panels). No 
clear differences were observed between TSTEM and TPEX cells with respect 
to degranulation, measured via the surface mobilization of CD107a (Fig 
25C, left panels). In response to TCR-independent stimulation with 
phorbol myristate acetate (PMA) and ionomycin, however, TPEX cells 
produced IFN-γ and TNF and mobilized CD107a at much higher 
frequencies than TSTEM cells, the functional superiority of which was 
therefore limited to conditions that mimicked antigen recognition events 
(Fig 25C, right panels).  
Figure 25 : Proliferation and effector function capacity of memory T cells 
subsets. A) Representative overlay of CD25 and CD69 expression by flow 
cytometry, from memory subsets stimulated with SEB (1ng/ml) for 24 hours. B) 
MFI of T-bet on activated cells (CD25+CD69+) for SEB stimulated subsets as in 
A or gated on total cells for unstimulated (Us) samples. Data are shown as 
median. N = 5. **P < 0.01; ***P < 0.001; ****P < 0.0001 (Paired t test). C)Left, 
representative donor (top) and overall frequencies (bottom) of cytokine 
production of memory T cell subsets, stimulated for 12 hours with αCD3/CD28 
in the presence of brefeldin A (1 µl/ml, Golgi Plug), monensin (0.67 µl/ml, Golgi 
Stop). Data are shown as median. N=7. *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001 (Paired t test). Right, representative donor (top) and overall 
frequencies (bottom) of cytokine production of memory T cell subsets FACS-
sorted as in A and B, stimulated for 3 hours with PMA/Ionomycin in the 
presence of brefeldin A (1 µl/ml, Golgi Plug), monensin (0.67 µl/ml, Golgi Stop). 
Data are shown as median. N=6. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 
0.0001 (Paired t test). 
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To achieve further information regarding differentiation status of TSTEM and 
TPEX we investigated telomere length, according to Single Telomere 
Length Analysis (STELA) (Fig 26). Measurement of telomere length 










between subsets, indicating that both TPEX and TSTEM underwent similar 
number of cell divisions. We finally sought to test the long-term 
repopulation capacity of these subsets by performing serial adoptive cell 
transfers (ACTs) in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) humanized 
mice in vivo (Fig 27A). Thus we FACS-sorted TPEX, TSTEM and TEM from 
healthy controls and adoptively transferred in recipient mice alongside 
CD8-depleted autologous PBMCs as support. Purified TEM failed to 
efficiently repopulate these mice following the first ACT (not shown), in line 
with previous data 25. While both TSTEM and TPEX expanded to similar 
numbers in primary hosts (not shown), TSTEM proliferated faster in the 
Figure 26 : Telomere length of memory T cell subsets. 6,000 TSTEMCM, 
TPEX and TEM cells were sorted from total PBMCs of six healthy donors and 
STELA assay was performed. Median telomere length of each subset is 
shown in figure. Data are shown as median. **P < 0.01 (RM one-way 
ANOVA). 
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blood (Fig 27B) and preferentially repopulated the spleen compared to 
TPEX at 4 weeks after retransfer in secondary hosts (Fig 27C).  
 
4.2.3  TPEX are committed to a terminally dysfunctional state 
Epigenetic regulation plays a key role in T cell fate decisions93. We 
therefore employed the Assay for Transposase-Accessible Chromatin 
using sequencing (ATACseq) to compare the open chromatin landscapes 
of TSTEM and TPEX cells in terms of differentially accessible regions (DARs). 
Figure 27 :TPEX display lower expansion capacity upon serial transfers in 
vivo A) Experimental layout of serial transplantation experiments. FACS-
purified T cell subsets were transferred retroorbitally in primary NSG 
recipients. 28 days post transfer, human T cells were isolated from spleen and 
lungs, the CD4:CD8 ratio normalized and T cells were subsequently 
transferred in secondary recipients. B) Absolute number of CD8+ T cells/µL in 
the peripheral blood (PB) at day 11, 18 and 28 after transfer of TSTEM and TPEX 
cells in secondary recipients. C) Total CD8+ T cells recovered in the spleen 
(SP) of secondary recipient mice treated as in H (day 28 post transfer). Data in 
I and J indicate n=4 mice/group; two pooled independent experiments). *P < 
0.05 (2-way ANOVA and Mann-Whitney test). In both graphs, data are shown 
as mean ± SEM. 
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Naive and TEM cells were analyzed in parallel as lineage controls. PCA in 
Fig 28A revealed  
 
Figure 28 : Chromatin accessibility analysis of memory T cell subsets. TN, 
TSTEM, TPEX and TEM cells were FACS-sorted from 3 HC’s peripheral blood and 
processed for ATACseq library generation and sequencing. A) Principal 
component (PC) analysis showing the distribution of the samples along the PCs. 
The numbers indicate the DARs between each subset. B) Heatmap showing 
ATAC-seq DARs. Genes relevant for memory, effector and exhaustion 
differentiation that show DARs are depicted in the yellow (open in TPEX) or blue 
(open in TSTEM) box. C) representative genomic regions showing the chromatin 
status for TOX, TIGIT and SATB1 in the two subsets in B. The peaks that are 
differentially open are highlighted in red. D) Transcription factor binding motifs 
enriched in DARs shown in B. The P value for each enrichment is indicated.   
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that TSTEM and TPEX cells were globally similar, although TSTEM cells 
mapped toward the naive subset, whereas TPEX cells mapped toward the 
TEM subset (Fig 28A). However, we also identified a total of 13,414 DARs 
between TSTEM and TPEX cells (Fig 28B). Genes associated with T cell 
dysfunction (e.g., TOX, TOX2, TIGIT, PDCD1, NFATC2, and MAF), 
terminal differentiation (e.g., ZEB2 and BATF), and other immune-related 
processes previously identified at the mRNA level (e.g., EOMES and 
GZMA) were more accessible in TPEX versus TSTEM cells (Fig. 28B and C). 
In contrast, genes associated with T cell memory (e.g., LEF1, SELL, 
CCR7, BACH2, and SATB1) and effector functions [e.g., GZMB, RORA160 
(Fig 28B and C). Computational analysis by HOMER in these DARs 
identified TF binding motifs (TFBMs) preferentially enriched in TSTEM vs. 
TPEX, and related to TFs generally expressed by less differentiated T cells 
(RUNX2, RUNX1, LEF1 and FOXP1), involved in effector differentiation 
(RORA) or mediating cytokine signaling (STAT5, STAT4 and STAT1). 
Instead, those motifs preferentially enriched in TPEX were related to TFs 
involved in effector differentiation but also in the specification of exhausted 
cells, such as TBX21 (encoding T-bet) and EOMES. The combined 
TBOX:SMAD motif was also identified in these cells (Fig 28D). The 
chromatin accessibility data suggested that TPEX cells were predisposed to 
the generation of dysfunctional progeny and susceptible to the inhibitory 
effects of TGF-β signaling via SMADs. Accordingly, TPEX cells proliferated 
to a lesser extent and produced less GZMB than TSTEM cells in response to 
stimulation with anti-CD3/CD28 and IL-15 (Fig. 29), recapitulating our 
previous data on the functional defects of TPEX cells also in this stimulation 
condition. The addition of TGF-β further inhibited these responses, 
especially the production of GZMB, in parallel cultures of TPEX cells, 
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whereas minimal effects were observed in parallel cultures of TSTEM cells 













Eventually, from the same dataset we also investigated multipotency of 
TSTEM, originally FACS sorted as PD-1-TIGIT-, and TPEX, originally isolated 
as PD-1+TIGIT+. Notably, TPEX cells generated a progeny that almost 
exclusively kept the same PD-1+TIGIT+ phenotype, while TSTEM resulted 
capable to generate all the phenotypical combinations of PD-1 and TIGIT, 
thus displaying increased plasticity compared to TPEX, which on the 
Figure 29: TPEX display dysfunctional traits after TCR stimulation.  FACS-
sorted memory subsets stimulated in vitro with αCD3/CD28 (beads to cell ratio 
= 1:2) together with IL15 (10 ng/ml) alone or in combination with TGFβ (10 
ng/ml). The histograms show the overlay from unstimulated (Unstim), 
aCD3/CD28 + IL15 and αCD3/CD28 + IL15 + TGF-B stimulated samples from 




opposite are strictly committed to generate a dysfunctional progeny in 
response to TCR stimulation (Fig 30).  
We then used RNAseq to profile the transcriptomes of TSTEM and TPEX 
cells after stimulation with anti-CD3/CD28 in the presence of IL-2 and IL-
12 (Fig 31A). Activated TSTEM preferentially expressed the memory-related 
genes BACH2, ID3, IL2 and SATB1 alongside the effector-related genes 
IRF8, RORC, GNLY, XBP1, IL26 and IL23R, whereas activated TPEX 
overexpressed genes related to dysfunctional cells such as TOX, PDCD1, 
TIGIT, MAF and CXCL13, the inhibitor of IL-2 production IKZF3, the TGFβ 
-induced TF SMAD3, the cytotoxicity-related molecules GZMK, GZMH and 
GZMA, as well as additional immune-related molecules, including multiple 
chemokines. 
Figure 30 : Differentiation potential of TSTEM and TPEX. Dot plots showing the 
phenotype of TSTEM and TPEX after sort and after four days of stimulation from one 
representative donor (left). Bar plot show pooled results for the TSTEM and TPEX 
progeny cell phenotype from all donors. Data are shown as median. N = 5. **P < 




Notably, some of these genes were previously found differentially 
expressed ex vivo (Fig. 23B). GSEA further revealed the functional vs. 
dysfunctional nature of TSTEM and TPEX, respectively, according to which 
TSTEM were preferentially enriched in gene sets related to less 
differentiated, non-exhausted or proliferating T cells, while TPEX in gene 
sets related to TGFβ and PD-1 signalling, PD-1high cells or exhausted T 
cell subsets identified in melanoma tumors by scRNA-seq 89 (Fig 31B). 
PCA of ATAC-seq data from paired samples showed that stimulation 
induced substantial changes in the  
Figure 31 : Transcriptome analysis of activated TSTEM and TPEX . A) Heatmap 
showing selected differentially expressed genes (Q value<0.05) by FACS-sorted 
TSTEM and TPEX stimulated as in Fig 28, B) Histogram plot showing the normalized 
enrichment score (NES) of selected pathways obtained from GSEA in activated 




chromatin accessibility landscape of both TSTEM and TPEX compared to 
controls ex vivo (Fig 32A). However, those major differences previously 
identified ex vivo and visible along PC2 were stably maintained both at the 
level of specific genes (Fig 32B) and of TFBM enrichment (Fig 32C), 
Figure 32 : Epigenetic landscape of activated TSTEM and TPEX . A) PCA as in 
Fig 25A of FACS sorted TSTEM and TPEX stimulated as in Fig 26 or left 
unstimulated. B) Heatmap showing DARs between activated TSTEM and TPEX 
cells. Genes relevant for memory, effector and exhaustion differentiation that 
show DARs are depicted in the yellow (open in TPEX) or blue (open in TSTEM) 
box. C) Transcription factor binding motifs enriched in DARs between activated 
TSTEM and TPEX cells. The P value for each enrichment is indicated. 
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thereby indicating that the two subsets follow distinct paths of 
differentiation that are epigenetically imprinted.  
Finally, we reasoned that the differences in effector, memory and 
exhaustion traits illustrated above might impact the functionality of T cells 
in vivo. In this regard, we used a stringent ACT protocol where cell 
products derived from naturally-occurring TSTEM and TPEX and redirected 
with a chimeric antigen receptor (CAR) targeting CD19 are transferred in 
tumor-bearing mice in the absence of human autologous CD4+ T cells or 
exogenous cytokines. We noticed that TSTEM displayed enhanced control 
of leukemic burden compared to TPEX at multiple time points following ACT 
in NSG mice previously injected with the acute lymphoblastic leukemia 
NALM6 cell line (Fig 33). Overall, our results indicate that TPEX are “hard-
wired” to their dysfunctional signature after immune  
activation and effector differentiation, while TSTEM are relatively resistant to 















4.2.4  TPEX cells are abundant in persistent infections and clonally 
distinct from TSTEM cells 
Dysfunctional, exhausted CD8+ T cells develop in response to persistent 
TCR stimulation161 thus we reasoned that TPEX cells could be more 
abundant in T cells specific for chronic versus acute infections. Recent 
works demonstrated that a single round of vaccination is known to induce 
a population of long-lived TSCM-phenotype cells in response to yellow fever 
virus (YFV)162,163. As we have shown that TSCM-phenotype cells are 
heterogeneous, we tested whether the vaccine-induced YFV-specific 
CD8+ T cells preferentially belong to the functional TSTEM or dysfunctional 
TPEX phenotype. In order to do this, we took advantage of publicly 
available gene expression data from vaccinated individuals. In this regard, 
we found that the YFV-specific TSCM-cells persisting years after 
vaccination shared a transcriptional identity with TSTEM but not with TPEX 
cells (Fig 34A).  In addition, we used MHC class I multimers to investigate  
 
Figure 33 : TSTEM display increased capacity to control tumor burden in 
vivo. Top: schematic layout of the adoptive transfer experiment. Bottom: relative 
luminescence units (RLU) measured overtime and indicating the growth of the 
NALM6 cells in NSG mice adoptively transferred with T cell subsets previously 
redirected with anti-CD19 chimeric antigen receptor (CAR19). Follow-up was 
stopped when >75% of mice from one of the treated group reached an RLU 
value ≥106. Data are shown as mean ± SEM. UT: unstransduced CD3+ T cells. 
*P < 0.05 (Unpaired t test and Mann-Whitney test). 
 
 92 
antigen-specific CD8+ T cells in response to different persistent (CMV and 
EBV) or non-persistent (Flu and Rotavirus)-related epitopes in 5 
individuals (2 of whom HIV+) by mass cytometry (CyTOF). As depicted in 
Fig 34B, We found that the CCR7+ fraction of CMV and EBV-specific CD8+ 
T cells had increased levels of the TPEX signature markers TIGIT, PD-1, 
GZMK, GZMA and CCR5 compared to that of the Flu-specific CD8+ T 
cells. This was more evident for EBV than CMV-related epitopes. We 
additionally found overexpression of the 2B4 receptor by cells specific for 
persistent viruses, suggesting that 2B4 can serve as an additional marker 
for their identification. No relevant differences were found between healthy 
Figure 34 : TPEX are more abundant in chronic Ag-specific memory pool. 
A) GSEA plot of YFV-specific CD8 T cell signature, derived from public gene 
expression data, in TSTEM versus TPEX cells. B) CyTOF plots showing overlay of 
total memory cells with TSTEM, TPEX and CCR7+ virus-specific fractions for Flu 
M1, EBV LMP2A and CMV pp65 epitopes. C) Ion count quantification by 
CyTOF of the markers analyzed in B. Flu (n=6) and Rotavirus (n=1) epitopes 
were labelled as “Acute” for simplicity. Each category (“Acute”, “CMV” and 
“EBV”) includes Epitope-specific responses from a single donor (for a total of 5 
donors) directed to the same virus were labelled as “CMV” or “EBV”. Total 
CD8 were also reported as a reference. *P < 0.05; **P < 0.01; ***P < 0.001 
(Unpaired t test and Mann-Whitney test). 
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and HIV+ donors. (Fig 34B and C) The abundance of TPEX cells was similar 
when measuring CMV-specific CD8+ T cells with high avidity for the TCR 
by the use of a point-mutated MHC class I tetramer164 thereby 
corroborating the recent idea that persistent stimulation rather than TCR 
signal strength generates dysfunctional CD8+ T cells (Fig 35). Overall, 










individuals, is preferentially associated with the development of a 
phenotype endowed with diminished functionality. We next performed 
deep sequencing of the TCR (TCRseq) in FACS-purified cells from 6 
different individuals to corroborate the evidence that T cell responses 
contained in TSTEM and TPEX memory subsets are directed towards 
Figure 35 : TPEX generation is not shaped by TCR avidity. Frequency of 
Ag-specific TPEX for HLA-A*0201/restricted CMV pp65495-503 NLVPMVATV 
(NV9) and CMV KA227/8 NLVPMVATV (KA) tetramers. n=7 (pp65) and 4 
(KA). 
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different epitopes. TEM cells were also sorted in parallel to test diversity 
and overlap of the TCR repertoire as a control. In line with their less-
differentiated memory identity, TPEX appeared as polyclonal as TSTEM 
memory cells when compared to the less diverse, oligoclonal TEM cells 
(Fig 36A) (analysis related to the most abundant 3,000 clones). Moreover, 
while both shared clones with TEM cells, TSTEM and TPEX showed little 
overlap between each other (Fig 36B and C), suggesting a divergent 
differentiation program capable to give rise to more differentiated effector 
T cell progeny.  
Figure 36: TCR repertoire analysis display little overlap between TSTEM 
and TPEX A) Normalized Shannon-Wiener index indicating the clonal diversity 
of the TCR repertoire for each population as determined by TCRβ chain deep 
sequencing. B) Summary of the pairwise comparison between subsets of the 
data in A (n=6). In both A and B, the horizontal bar indicates the median. *P < 
0.05, **P < 0.01; Diversity (D) metrics. C) Venn diagram shows overlap of top 
3000 TCR clonotypes shared between TSTEM, TPEX, and TEM subsets from a 
representative donor. 
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5  Discussion 
The CD8+ TN cell compartment has been shown during last years to be 
composed by distinct subsets, including cells that display clear memory 
traits despite their naïve-like phenotype, such as TSCM25,30  and CXCR3bright 
TMNP cells141. With this project, we demonstrated that truly naïve human 
CD8+ T cells, as defined by a plethora of assays, possess distinct 
features. We have identified two populations of CD8+ TN cells on the basis 
of the expression of CXCR3, defined as TNR3- and TNR3+.  
TNR3+ displayed increased cytokine production capability, both after 
mitogen and cognate antigen stimulation in vitro, augmented effector 
differentiation potential after foreign antigen encounter, both in vivo and in 
vitro, and overexpressed a different set of genes compared to TNR3-. 
These features correlated with physico-chemical properties of TRB CDR3, 
thus suggesting that TNR3+ cells bear TCRs with equivalent diversity 
compared to TNR3-, but increased strength of interaction with p:MHC 
complexes. Furthermore, human TNR3+ cells display a shared 
transcriptional identity with their murine counterparts, which are comprised 
in the CD5hi fraction of CD44lo CD62Lhi TN cells. In the mouse, the 
potential to respond to foreign antigen correlates with TCR sensitivity for 
self-antigens72, and such sensitivity in turn correlates with surface CD5 
expression70–73. Thus, FACS-sorted CD5hi TN cells, that included TNR3+ 
cells72, displayed a gene expression profile featuring increased levels of 
transcripts related to cell cycle and effector differentiation, such as Tbx21, 
Eomes and Cxcr3, compared to CD5lo cells72. In fact, according to gene 
expression data, a small subset of murine CD5hi also expresses CXCR372 
(Fig 16A). In our hands, these murine TNR3+ cells revealed increased 
expression of genes related to effector differentiation compared to both 
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CD5lo and CD5hi cells, also displaying a transcriptional identity shared with 
human TNR3+. 
The human TCR repertoire is highly polyclonal, thus to further investigate 
the potency of immune response we took advantage of the mouse TN 
pool, where well known affinity for self-derived Ags can be exploited. In the 
context of transgenic TCR, murine TNR3+ cells displayed slightly, but 
significantly increased capability to generate KLRGhi IL-7Rlo SLECs 
following acute LCMV infection. Interestingly, even in the presence of 
normalized TCR, TNR3+ cells displayed to be poised to effector 
differentiation, thus suggesting an intrinsic pre-commitment of TN subsets. 
Collectively, these murine data indicate that murine TN cell subsets that 
are equivalent to those from humans are differentially committed to 
generate effector T cell progenies following activation, thereby 
corroborating the evidence that effector differentiation potential is shaped 
at the level of the preimmune repertoire. 
CD5 has been recently used as an indicator of human CD8+ T cell affinity 
for self74. However, we have shown that CD5 expression is not capable to 
segregate subsets of TNR3- and TNR3+ (Fig 16A), thus questioning its role 
in defining TN heterogeneity in humans. Taken together, these 
observations and the differential bias for effector differentiation correlating 
with CXCR3 expression suggest that CXCR3 is a more efficient marker to 
identify TN cells with increased effector capacity. 
Recently, work from Alanio and colleagues165 demonstrated that memory-
phenotype CD8+ T cells display a mechanism of retention in the thymus 
and the skin which is driven by CXCR3/CXCL10 axis in unimmunized 
mice. According to our data, TNR3+ are not present in mucosal tissues (i.e 
skin gut and lung, Fig 7A) and do not preferentially home to specific 
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organs in the periphery. On the other hand, they are relatively abundant in 
PB and LNs. Although in the mouse there is previous evidence of TN-
phenotype or pre-activated TN cells entering non-lymphoid organs (i.e. 
lung, gut) 166,167, our data are in line with a recent report by Thome et al, 
who have shown the virtual absence of TN cells in human mucosal 
tissues133. Work from Annunziato and colleagues168 demonstrated that 
CCR7 and CXCR3 expression are mutually exclusive within human 
thymocytes. Additionally, previous work from our collaborator revealed that 
CXCR3 signaling is absent in CD8+ TN and TMEM at the steady-state but 
increased with TCR triggering169. Furthermore, also chemokines ligand of 
CXCR3 are present at low levels at the steady state, while increase with 
inflammation170,171.These observations, together with the absence of the 
tissue-residency markers CD69 and CD103, suggests a constant 
recirculation between PB and LNs of TN subsets and argue against a role 
of CXCR3 in TN cell physiology and homeostasis in the absence of 
cognate Ag stimulation. According to our data, TNR3+ might have a 
migratory advantage over TNR3- only after T cell activation, in line with 
what has been reported for murine TCM, which are capable of rapid 
localization to peripheral areas of LNs after Ag exposure thanks to their 
preferential expression of CXCR3171.  
TNR3+ cells display only a modest 2-fold dilution in TREC content 
compared to TNR3-, which represent an average of one cell division. In our 
opinion, this small entity dilution is not sufficient to allow the identification 
of CD8+ counterpart of CD4+CD31+ Recent Thymic Emigrants (RTE), 
which instead display a TREC content on average 8 times higher than 
CD4+CD31-172. However, TREC dilution of TNR3+ cells suggests a higher 
turnover due to homeostatic proliferation, in line with what observed by 
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Cho and colleagues, which demonstrated that murine CD5hi responded 
better to lymphopenia-induced proliferation than CD5lo TN cells73. 
According to their naive status, CXCR3 upregulation in TNR3+ cells is not 
driven by antigen recognition. Instead, increased homeostatic proliferation 
of TNR3+ cells might play a role in this regard. In particular, increased tonic 
signaling due to distinct TCRs with intrinsic affinity for self-Ags may cause 
a higher rate homeostatic proliferation which can in turn drive CXCR3 
upregulation. This speculation is in line with recent findings from Kato and 
colleagues, which demonstrated the conversion of TNR3- cells in TNR3+ at 
slow cell division rate in lymphopenic mice173. Interestingly, recent work 
from Smith et al supports this hypothesis. Indeed, they demonstrated that 
the murine TN pool is organized in developmental layers in response to 
infection, with a fetal layer of cells, which displayed some degree of 
overlap with TNR3+, prone to effector differentiation while cells composing 
the adult layer tended to generate a long-lived memory progeny174.  
Collectively, with this project we demonstrated that the human and murine 
TN compartments are composed by at least two subsets which can be 
defined on the basis of CXCR3 expression. TNR3+ are characterized by 
enhanced capability to differentiate in functional effector cells, thus 
providing a selective advantage during an immune response. It is still 
unclear why a subset prone to generate a less efficient progeny, i.e., the 
TNR3- cells is evolutionary maintained, but it is tempting to speculate that 
their persistence may avoid the generation of “holes” in the TCR repertoire 
that pathogens could potentially exploit. Thus, TNR3- cells could represent 
an efficient strategy to guarantee a polyclonal immune response, albeit at 
lower magnitude175. 
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Overall, with this project we brought attention to the quality of preimmune 
repertoire as an additional layer of functional and transcriptional regulation 
of effector T cell responses in humans.  
In the second part of the project, we have better defined long-lived 
memory T cell differentiation, where stem-like CD8+ memory T cells with 
strong proliferative capacity are identified as CCR7+ PD-1-TIGIT- 
independently of their TSCM or TCM phenotype. Prior to our study, the 
discovery of TSCM defined this subset as a progenitor for the memory 
compartment equipped with enhanced proliferative capacity and anti-
tumor properties25. Conversely, TCM present higher cytotoxic properties 
compared to TSCM but lower multipotency and persistence. As a 
consequence, TSCM were proposed as the most promising cell product for 
cancer immunotherapy176. In light of our data, the differences previously 
ascribed to TSCM and TCM can be largely explained to a differential 
contamination of the transcriptionally and functionally distinct TPEX cells 
within these subsets. Our results suggest that the generation of a cell 
product with a defined PD-1-TIGIT- phenotype from TN precursors, 
independent from previous TSCM and TCM definition, will enhance the 
beneficial properties of adoptive transfer of CAR-engineered T cells in 
cancer treatment. Indeed, this will provide a population of T cells 
(CCR7+GZMK-PD-1-TIGIT-, TSTEM) with improved self-renewal, proliferative 
and cytotoxic potential. Additionally, the identification of a larger pool of 
progenitors with enhanced stem-like properties, the TSTEM, compared to 
TSCM cells, could overcome the limitation of small numbers to be redirected 
with CARs ex vivo. 
Moreover, we characterized a subset of T cells that we defined TPEX, 
simultaneously featuring long-lived memory and dysfunctional traits at the 
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gene expression, epigenetic and functional level, resembling stem-like 
progenitors of exhausted T cells recently identified in the context of 
chronic viral infections and cancer. Earlier studies defined a dichotomy 
within the TEX compartment, according to which terminally differentiated 
TCF1- and progenitor TCF1+ subsets can be identified82,83,88,177. On the 
basis of these data, it has been proposed that exhaustion differentiation 
mirrors memory T cell differentiation despite their developmental 
relationships remain unclear75,178. Our data on clonal divergence of TSTEM 
and TPEX cells strongly supports the concept that layers of memory T cells 
exist in humans with parallel programs of differentiation. The recent 
identification of TOX as a specific driver of exhaustion via epigenetic 
modifications99–102,155 further confirms that memory and exhaustion 
differentiation are governed by distinct mechanisms. In humans, TPEX 
express increased levels of TOX mRNA and show preferential 
accessibility of the TOX gene compared to TSTEM. On a functional level, 
this reflects on lower proliferation and production of cytokines such as IFN-
γ, IL-2 and TNF-a compared to TSTEM, although we did not formally 
address whether this is due to TOX or to expression of additional factors 
previously linked to exhaustion. Moreover, the sensitivity to the 
suppressive cytokine TGFβ corroborated the predisposition to dysfunction 
by TPEX compared to TSTEM cells. Interestingly, TPEX express markers that 
are important for long-lived memory T cell homeostasis (e.g., CCR7, 
LEF1), and have a polyclonal TCR repertoire, indicating that they behave 
as stem-like precursors. However, such repertoires are largely distinct, 
thereby suggesting that these subsets target different specificities. TPEX 
cells are present in healthy individuals and preferentially develop in 
response to epitopes from persistent pathogens, indicating that these 
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long-lived memory T cells adapt to persistent/repeated epitope stimulation 
by acquiring hybrid characteristics (i.e. simultaneously featuring early 
memory and dysfunctional/exhausted-like traits). A limitation of the study 
could be that no history of the blood donor cohort is available apart from 
age and sex. We have investigated the response to highly prevalent 
pathogens, like EBV and CMV, and we have shown that TPEX preferentially 
develop in response to these chronic pathogens. Notably, prevalence of 
EBV is >90% in the population179, and is thus thought to influence the 
cohort only marginally. Differently, prevalence of CMV is 60% ca. in the 
European region180. Future investigations will have to address the impact 
of CMV infection on the distribution of TPEX and TSTEM subsets among 
CD8+ T cells. Notably, we observed a significantly higher proliferation of 
TPEX cells compared to TEM, implying that these cells are not terminally 
differentiated, rather are still capable to expand and exert effector 
functions in response to their cognate Ag. However, while sorted TSTEM 
cells gave origin to the full spectrum of cells on the basis of PD-1 and 
TIGIT expression, TPEX cells generated only PD-1+TIGIT+ cells suggesting 
a decreased differentiation plasticity that was further corroborated by 
transcriptional and epigenetic investigations. These results imply that the 
epigenetic and gene expression profiles of TSTEM cells is more dynamic 
and plastic compared to TPEX cells, which are instead committed to the 
generation of dysfunctional cells. Although the benefit of the generation of 
a dysfunctional lineage might be not clear, TPEX are still capable to exert 
effector activities, albeit at lower magnitude compared to TSTEM. This 
scenario is also reminiscent of T cell functionality in response to chronic 
infections, where exhausted T cells, despite limited in their effector 
functions, are still capable to exert some control of viral replication. In line 
 102
with this observation, Jin et al have shown that chronically SIV infected 
macaques experience increased viral load following CD8+ T cell 
depletion181. More recently, Alfei et al have shown that Tox-deleted virus-
specific T cells abrogate the exhaustion program, undergo effector 
differentiation and induce lung tissue destruction101, suggesting that 
exhaustion indeed limits immunopathology while ensuring some level of 
persistence and viral control. Importantly, upon activation, TSTEM co-
express stem and effector genes while being relatively resistant to 
exhaustion178, thus suggesting that the promotion of a stem/effector hybrid 
phenotype would be beneficial for long-term anti-tumor immunity. This is 
reminiscent of recent data from Lynn and colleagues, who generated 
exhaustion-resistant CAR T cells by overexpressing c-Jun182. Further 
studies will be required to test whether induction of the transcriptional 
program of TSTEM may result in similar functional capacity.  
Overall our work demonstrates that TPEX cells represent a population with 
unique hybrid characteristics that localizes within the very early stages of 
the “exhaustion differentiation branch” and that so far was included within 
the classical memory pool (i.e. TSCM and TCM). We propose that pre-
existing differences on gene expression profile and epigenetic imprinting 
along with TCR specific for chronic antigens allow the commitment to 
CCR7+ GZMK+ PD-1+ TIGIT+ TPEX cells that may represent the initial step 
of exhaustion differentiation. 
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